KR102609440B1 - Mixed feed for livestock including black soldier fly, almond shell and egg shell - Google Patents
Mixed feed for livestock including black soldier fly, almond shell and egg shell Download PDFInfo
- Publication number
- KR102609440B1 KR102609440B1 KR1020210069158A KR20210069158A KR102609440B1 KR 102609440 B1 KR102609440 B1 KR 102609440B1 KR 1020210069158 A KR1020210069158 A KR 1020210069158A KR 20210069158 A KR20210069158 A KR 20210069158A KR 102609440 B1 KR102609440 B1 KR 102609440B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- almond
- livestock
- black soldier
- Prior art date
Links
- 244000144972 livestock Species 0.000 title claims abstract description 69
- 235000020224 almond Nutrition 0.000 title claims abstract description 46
- 210000003278 egg shell Anatomy 0.000 title claims abstract description 45
- 235000011437 Amygdalus communis Nutrition 0.000 title claims abstract description 42
- 102000002322 Egg Proteins Human genes 0.000 title claims description 11
- 108010000912 Egg Proteins Proteins 0.000 title claims description 11
- 241000709785 Hermetia illucens Species 0.000 title claims description 10
- 241000220304 Prunus dulcis Species 0.000 title abstract 6
- 241001481656 Stratiomyidae Species 0.000 claims abstract description 35
- 210000004369 blood Anatomy 0.000 claims abstract description 35
- 239000008280 blood Substances 0.000 claims abstract description 35
- 239000002075 main ingredient Substances 0.000 claims abstract description 3
- 241000237536 Mytilus edulis Species 0.000 claims description 44
- 235000020638 mussel Nutrition 0.000 claims description 44
- 239000000843 powder Substances 0.000 claims description 43
- 235000021277 colostrum Nutrition 0.000 claims description 41
- 210000003022 colostrum Anatomy 0.000 claims description 41
- 244000144725 Amygdalus communis Species 0.000 claims description 40
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 35
- 239000011707 mineral Substances 0.000 claims description 35
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims description 23
- 241001474374 Blennius Species 0.000 claims description 22
- 239000011575 calcium Substances 0.000 claims description 21
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 20
- 229910052791 calcium Inorganic materials 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 229940016409 methylsulfonylmethane Drugs 0.000 claims description 18
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 17
- 240000002900 Arthrospira platensis Species 0.000 claims description 17
- 229940082787 spirulina Drugs 0.000 claims description 17
- 235000010469 Glycine max Nutrition 0.000 claims description 16
- 240000003183 Manihot esculenta Species 0.000 claims description 16
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 16
- 244000068988 Glycine max Species 0.000 claims description 15
- 239000000419 plant extract Substances 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 13
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 13
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 240000007594 Oryza sativa Species 0.000 claims description 12
- 235000007164 Oryza sativa Nutrition 0.000 claims description 12
- 235000009566 rice Nutrition 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 11
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 10
- 244000020518 Carthamus tinctorius Species 0.000 claims description 10
- 239000006014 omega-3 oil Substances 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 8
- 150000002482 oligosaccharides Chemical class 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 abstract description 25
- 108090000623 proteins and genes Proteins 0.000 abstract description 25
- 235000015097 nutrients Nutrition 0.000 abstract description 23
- 235000013305 food Nutrition 0.000 abstract description 22
- 239000006227 byproduct Substances 0.000 abstract description 10
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 235000013372 meat Nutrition 0.000 abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 62
- 239000013535 sea water Substances 0.000 description 34
- 235000010755 mineral Nutrition 0.000 description 33
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000001035 drying Methods 0.000 description 20
- 239000000284 extract Substances 0.000 description 20
- 241000283690 Bos taurus Species 0.000 description 19
- 239000000203 mixture Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000004310 lactic acid Substances 0.000 description 15
- 235000014655 lactic acid Nutrition 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- 235000013601 eggs Nutrition 0.000 description 13
- 239000004615 ingredient Substances 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000004927 clay Substances 0.000 description 9
- 239000010881 fly ash Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 239000002689 soil Substances 0.000 description 9
- 241000238631 Hexapoda Species 0.000 description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 8
- 239000003925 fat Substances 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 241000512259 Ascophyllum nodosum Species 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000000749 insecticidal effect Effects 0.000 description 7
- 238000010298 pulverizing process Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 7
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 108090000317 Chymotrypsin Proteins 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 229960002376 chymotrypsin Drugs 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003344 environmental pollutant Substances 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 231100000719 pollutant Toxicity 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- 241000255925 Diptera Species 0.000 description 5
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 4
- 235000019750 Crude protein Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 240000004460 Tanacetum coccineum Species 0.000 description 4
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 4
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 4
- -1 etc. Substances 0.000 description 4
- 229910003472 fullerene Inorganic materials 0.000 description 4
- 230000012447 hatching Effects 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 229940015367 pyrethrum Drugs 0.000 description 4
- 229940048383 pyrethrum extract Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 244000301850 Cupressus sempervirens Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- 102000012286 Chitinases Human genes 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 241001537211 Perna canaliculus Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 description 2
- 240000003085 Quassia amara Species 0.000 description 2
- 235000009694 Quassia amara Nutrition 0.000 description 2
- IOSXSVZRTUWBHC-LBTVDEKVSA-N Quassin Chemical compound CC([C@@H]1CC(=O)O[C@@H]([C@]21C)C1)=C(OC)C(=O)[C@@H]2[C@]2(C)[C@@H]1[C@H](C)C=C(OC)C2=O IOSXSVZRTUWBHC-LBTVDEKVSA-N 0.000 description 2
- 241001253920 Ryania Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 230000001418 larval effect Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 description 2
- IOSXSVZRTUWBHC-UHFFFAOYSA-N quassin Natural products C1C(C23C)OC(=O)CC3C(C)=C(OC)C(=O)C2C2(C)C1C(C)C=C(OC)C2=O IOSXSVZRTUWBHC-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 241001660788 Cinchona calisaya Species 0.000 description 1
- 241000252203 Clupea harengus Species 0.000 description 1
- 241000255749 Coccinellidae Species 0.000 description 1
- 206010069729 Collateral circulation Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000006479 Cyme Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241001112724 Lactobacillales Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 241000721654 Lepomis macrochirus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000192129 Leuconostoc lactis Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000004659 Picrasma quassioides Species 0.000 description 1
- 235000010913 Picrasma quassioides Nutrition 0.000 description 1
- 235000017372 Piretro di Dalmazia Nutrition 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241001253901 Ryania speciosa Species 0.000 description 1
- 229930001406 Ryanodine Natural products 0.000 description 1
- 241000566137 Sagittarius Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 235000011984 Simarouba amara Nutrition 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000250966 Tanacetum cinerariifolium Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241000186882 Weissella viridescens Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- VXSIXFKKSNGRRO-MXOVTSAMSA-N [(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[(1s)-2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-3-[(e)-3-methoxy-2-methyl-3-oxoprop-1-enyl Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1.CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VXSIXFKKSNGRRO-MXOVTSAMSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium peroxydisulfate Substances [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- VAZSKTXWXKYQJF-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)OOS([O-])=O VAZSKTXWXKYQJF-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000010868 animal carcass Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000021038 drupes Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 235000019514 herring Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012229 microporous material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000006272 natural pesticide Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000010893 paper waste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000019617 pupation Effects 0.000 description 1
- 229940070846 pyrethrins Drugs 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000029865 regulation of blood pressure Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- JJSYXNQGLHBRRK-SFEDZAPPSA-N ryanodine Chemical compound O([C@@H]1[C@]([C@@]2([C@]3(O)[C@]45O[C@@]2(O)C[C@]([C@]4(CC[C@H](C)[C@H]5O)O)(C)[C@@]31O)C)(O)C(C)C)C(=O)C1=CC=CN1 JJSYXNQGLHBRRK-SFEDZAPPSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- DYVLCKBKORVXAT-UHFFFAOYSA-L silver;sodium;3-carboxy-3-hydroxypentanedioate Chemical compound [Na+].[Ag+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O DYVLCKBKORVXAT-UHFFFAOYSA-L 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- VWDWKYIASSYTQR-YTBWXGASSA-N sodium;dioxido(oxo)azanium Chemical compound [Na+].[O-][15N+]([O-])=O VWDWKYIASSYTQR-YTBWXGASSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
- A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/807—Poultry or ruminant feed
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physiology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Botany (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Abstract
본 발명은 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료에 관한 것이다.
본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료는 동애등에, 아몬드피 및 난각을 주성분으로 포함한다.
상기한 구성에 의해 본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료는 친환경 미래 대체 단백질원인 동애등에와, 농식품 부산물인 아몬드피, 난각 등을 포함함으로써 동애등에, 아몬드피, 난각에 풍부하게 함유되어 있는 단백질, 지방 등의 영양소를 용이하게 섭취하여 가축의 육질을 개선할 수 있고 농식품 부산물의 영양학적 및 사료적 가치를 제고할 수 있다.The present invention relates to a mixed feed for livestock containing black soldier flies, almond blood, and egg shells.
The mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention contains black soldier flies, almond blood, and egg shells as main ingredients.
With the above-described structure, the mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention contains black soldier flies, which are eco-friendly future alternative protein sources, and almond blood, egg shells, etc., which are agricultural food by-products. By easily ingesting nutrients such as protein and fat, which are abundant in egg shells, the meat quality of livestock can be improved and the nutritional and feed value of agricultural food by-products can be improved.
Description
본 발명은 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료에 관한 것으로서, 더욱 상세하게는 친환경 미래 대체 단백질원인 동애등에와, 농식품 부산물인 아몬드피, 난각 등을 포함하여 가축용 배합사료를 제조함으로써, 동애등에, 아몬드피, 난각에 풍부하게 함유되어 있는 단백질, 지방 등의 영양소를 용이하게 섭취하여 가축의 육질을 개선할 수 있고 농식품 부산물의 영양학적 및 사료적 가치를 제고할 수 있는 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료에 관한 것이다.The present invention relates to a mixed feed for livestock containing black soldier flies, almond blood, and egg shells, and more specifically, to a mixed feed for livestock containing black soldier flies, which are eco-friendly future alternative protein sources, and almond blood, egg shells, etc., which are agricultural food by-products. By manufacturing black soldier flies, almond skin, and egg shells can easily consume nutrients such as protein and fat, which are abundant in black soldier flies, improving the meat quality of livestock and enhancing the nutritional and feed value of agricultural food by-products. This relates to a mixed feed for livestock containing back, almond blood, and egg shells.
인간이 가축을 사육하기 시작함과 더불어 소, 돼지, 닭 등의 가축에게 곡물 등의 사료를 공급하기 시작하였고 이렇게 사육된 가축으로부터 인간은 단백질의 대부분을 공급받고 생체 내에서 합성할 수 없는 영양소를 가축을 통해 얻고 있다.As humans began to raise livestock, they began to supply feed such as grains to livestock such as cows, pigs, and chickens. From livestock raised in this way, humans receive most of their protein and nutrients that cannot be synthesized in the living body. It is obtained through livestock.
그러나 전 세계 인구의 급격한 증가로 인하여 가축의 수요도 급증하여 사료의 양이 상대적으로 부족해지고 있는 것이 현실이다. 따라서 가축에의 사료 공급에 있어서 단순 사료의 증산뿐만 아니라 보다 적은 비용과 노력으로 가축의 증체 효과는 물론 다양한 기능성 효과도 함께 가지는 사료첨가제에 대한 관심이 높아지고 연구도 활발하게 진행되고 있다.However, due to the rapid increase in the world's population, the demand for livestock is also rapidly increasing, and the amount of feed is becoming relatively scarce. Therefore, in the supply of feed to livestock, interest is increasing and research is actively being conducted on feed additives that not only increase the production of feed but also increase the body weight of livestock with less cost and effort and have various functional effects.
또한, 가축의 비육과 소화를 촉진시키고 기능성 축산물을 생산할 수 있는 사료첨가제의 개발은 수입 대체에 따른 외화의 낭비를 막을 수 있을 뿐만 아니라 고품격 기능성 축산물을 생산하여 농가의 소득수준 향상에 기여할 수 있다.In addition, the development of feed additives that can promote fattening and digestion of livestock and produce functional livestock products can not only prevent the waste of foreign currency due to import substitution, but also contribute to improving the income level of farmers by producing high-quality functional livestock products.
한편, 동애등에는 절지동물 곤충강 파리목 동애등에과에 속하는 곤충으로 몸길이는 13 내지 20mm이며 전체적인 색상은 흑색이다. 서식지는 미국, 인도, 호주, 베트남, 한국 등 전 세계적으로 분포되어 있다.Meanwhile, black soldier flies are insects belonging to the arthropod insect class, Diptera, black soldier flies, with a body length of 13 to 20 mm and an overall black color. Its habitat is distributed around the world, including the United States, India, Australia, Vietnam, and Korea.
일반적으로 동애등에는 유기성 폐기물인 동물 사체, 가축의 분, 식물 잔재물, 음식물 쓰레기를 먹이로 하여 서식하며, 특히 동애등에를 사육하는 경우 대부분 음식물 쓰레기를 먹이로 사용하고 있다.In general, black soldier flies live on organic waste such as animal carcasses, livestock feces, plant residues, and food waste. In particular, when breeding black soldier flies, food waste is mostly used as food.
동애등에는 알에서 3일, 유충단계 15일, 번데기 14일, 성충 10일, 총 42일 여간의 생명 주기(life cycle)를 가지고 있으며, 유충 단계에서 번데기 단계로 전환될 때 높은 곳으로 이동하려는 습성을 이용하여 먹이와 동애등에를 분리한다. 일반적으로, 영양상태가 가장 우수한 번데기가 되기 전 상태인 노숙 유충을 이용하여 양돈 사료 내 첨가한다.Black soldier flies have a life cycle of 3 days in the egg stage, 15 days in the larval stage, 14 days in the pupa stage, and 10 days in the adult stage, a total of 42 days. When they transition from the larval stage to the pupal stage, they try to move to a higher place. Separate food and black soldier flies using their habits. Generally, it is added to pig feed using old-aged larvae, which are in the state before pupation, which have the best nutritional status.
동애등에는 가축이 필요로 하는 주영양소인 단백질 약 40%, 지방 약 20%를 함유하고 있으며, 특히 중쇄 지방산인 라우르 산(Lauric acid)과 불포화 지방산인 올레산(Oleic acid) 및 리놀산(Linoleic acid) 등 가축 사육에 유용한 영양소를 다량 함유하고 있는 것으로 알려져 있다.Dongae etc. contain about 40% protein and 20% fat, which are the main nutrients needed by livestock, especially medium-chain fatty acid Lauric acid and unsaturated fatty acid Oleic acid and Linoleic acid. It is known to contain a large amount of nutrients useful for raising livestock, such as ).
이에 동애등에는 가축용 사료로서 이용되고 있으나, 보다 효율적인 가축 사육을 위해, 동애등에를 이용한 가축 사료용 조성물의 유용한 영양소의 함량을 높일 필요가 있다.Accordingly, black soldier flies are used as livestock feed, but for more efficient livestock breeding, there is a need to increase the content of useful nutrients in livestock feed compositions using black soldier flies.
그리고 아몬드는 불포화지방산이 풍부하고 비타민 E가 풍부하여 피부 미용에도 좋으며, 철분이나 칼슘도 풍부해 건강에 좋다. 따라서 최근에는 많은 사람들이 식용으로 애용하고 있는데, 이러한 아몬드의 섭취방법으로는 통째로 섭취하거나 슬라이스 하여 부재료로 이용하거나 우유와 함께 갈아서 마시기도 한다.Almonds are also rich in unsaturated fatty acids and vitamin E, which are good for skin care. They are also rich in iron and calcium, so they are good for your health. Therefore, in recent years, many people have been using them as food. The way to consume almonds is by consuming them whole, slicing them and using them as an auxiliary ingredient, or grinding them with milk and drinking them.
상기 아몬드피는 아몬드에서 기름을 짜내고 남은 깻묵일 수 있는데, 상기 아몬드피에는 조단백질, 조섬유, 조지방 등의 함량이 높다.The almond blood may be seed cake left after oil is squeezed out of almonds, and the almond blood has a high content of crude protein, crude fiber, and crude fat.
또한, 난각(egg-shell, 卵殼, 달걀껍질)의 경우 부화에 실패한 무정란인 '부화중지란'이 발생하고 있으며, 이런 부화중지란은 부화 후 남은 난각, 부화 중 깨진 액란 등과 함께 폐기물 관리법에 의거하여 사업장폐기물로 폐기물 처리업자가 수거해 처리하게 된다.In addition, in the case of egg-shells, 'aborted eggs', which are unfertilized eggs that fail to hatch, are occurring, and these aborted eggs, along with eggshells remaining after hatching and liquid eggs broken during hatching, are subject to waste management laws. Accordingly, waste disposal companies collect and dispose of industrial waste.
그러나 이런 부화폐기물 발생량이 연간 6천톤이 넘는 수준이며, 처리비용도 많이 소요되고 있다. 난각의 경우 특히 부화 폐기물에는 조단백질, 철분, 칼슘 등 영양소가 풍부해 사료 원료, 유기질퇴비 원료, 메탄가스 원료 등으로 충분히 활용이 가능하나, 현재의 시스템에서는 고품질의 원료를 지속적으로 폐기하고 있는 실정이다.However, the amount of such hatching waste generated exceeds 6,000 tons per year, and disposal costs are high. In the case of eggshells, hatching waste in particular is rich in nutrients such as crude protein, iron, and calcium, so it can be fully utilized as feed raw materials, organic compost raw materials, and methane gas raw materials. However, in the current system, high-quality raw materials are continuously discarded. .
이에, 본 발명자는 친환경 미래 대체 단백질원인 동애등에와, 아몬드피, 난각 등과 같은 농식품 부산물을 이용하여 가축 사료용 조성물을 연구하던 중, 가축 사육에 필수적인 주영양소인 단백질, 지방 등을 다량 함유하고 있는 동애등에, 아몬드피, 난각 등을 포함하여 가축용 배합사료를 제조함으로써 가축의 사료 선호도를 높일 수 있고 가축의 건강 및 체중 증가를 향상시킬 수 있음을 확인하고 본 발명을 완성하였다.Accordingly, while researching compositions for livestock feed using agricultural food by-products such as black soldier fly, almond skin, and eggshell, which are environmentally friendly future alternative protein sources, the present inventor discovered black soldier fly, which contains large amounts of protein and fat, which are the main nutrients essential for livestock breeding. The present invention was completed after confirming that the feed preference of livestock can be increased and the health and weight gain of livestock can be improved by manufacturing a mixed feed for livestock including almond skin, egg shells, etc.
본 발명은 친환경 미래 대체 단백질원인 동애등에와, 농식품 부산물인 아몬드피, 난각 등을 포함하여 가축용 배합사료를 제조함으로써 동애등에, 아몬드피, 난각에 풍부하게 함유되어 있는 단백질, 지방 등의 영양소를 용이하게 섭취하여 가축의 육질을 개선할 수 있고 농식품 부산물의 영양학적 및 사료적 가치를 제고할 수 있는 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료를 제공하는데 있다.The present invention manufactures a mixed feed for livestock including black soldier fly, which is an eco-friendly alternative protein source for the future, and almond skin and egg shells, which are agricultural food by-products, thereby extracting nutrients such as protein and fat, which are abundant in black soldier fly, almond blood, and egg shells. The aim is to provide a mixed feed for livestock containing black soldier flies, almond skin, and egg shells that can be easily consumed to improve the meat quality of livestock and to enhance the nutritional and feed value of agricultural food by-products.
또한, 본 발명은 가축 사육에 필수적인 영양성분이 풍부한 동애등에, 아몬드피, 난각을 포함하여 가축용 배합사료를 제조함으로써 가축의 사료 선호도를 높일 수 있고 영양 성분이 균형있고 풍부하게 함유되어 있어 가축의 건강 및 체중 증가를 향상시킬 수 있는 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료를 제공하는데 있다.In addition, the present invention can increase the feed preference of livestock by manufacturing a mixed feed for livestock including black soldier flies, almond blood, and egg shells, which are rich in nutrients essential for livestock breeding. The nutritional ingredients are balanced and abundant, making it possible to increase the feed preference of livestock. The goal is to provide mixed feed for livestock containing black soldier flies, almond blood, and egg shells that can improve health and weight gain.
본 발명이 해결하고자 하는 다양한 과제들은 이상에서 언급한 과제들에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.The various problems to be solved by the present invention are not limited to the problems mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료는 동애등에, 아몬드피 및 난각을 주성분으로 포함한다.The mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention contains black soldier flies, almond blood, and egg shells as main ingredients.
상기 동애등에, 아몬드피 및 난각 이외에, 메틸설포닐메탄, 초록입홍합, 해조칼슘, 홍화씨, 키토산올리고당, 스피룰리나(spirulina), 액상미네랄, 식물추출물, 오메가-3 지방산, 초유분말, 타피오카 전분, 미강 및 대두분말을 더 포함할 수 있다.In addition to the above black soldier flies, almond blood and eggshells, methylsulfonylmethane, green-lipped mussels, seaweed calcium, safflower seeds, chitosan oligosaccharides, spirulina, liquid minerals, plant extracts, omega-3 fatty acids, colostrum powder, tapioca starch, and rice bran. And it may further include soybean powder.
상기 동애등에 40 내지 60 중량부, 아몬드피 10 내지 20 중량부, 난각 10 내지 20 중량부, 메틸설포닐메탄 5 내지 15 중량부, 초록입홍합 5 내지 15 중량부, 해조칼슘 1 내지 3 중량부, 홍화씨 1 내지 3 중량부, 키토산올리고당 0.5 내지 2.5 중량부, 스피룰리나(spirulina) 3 내지 7 중량부, 액상미네랄 1 내지 3 중량부, 식물추출물 1 내지 3 중량부, 오메가-3 지방산 2 내지 4 중량부, 초유분말 0.5 내지 1.5 중량부, 타피오카 전분 5 내지 15 중량부, 미강 10 내지 20 중량부 및 대두분말 1 내지 5 중량부의 중량 비율로 포함될 수 있다.40 to 60 parts by weight of Dongae, 10 to 20 parts by weight of almond blood, 10 to 20 parts by weight of eggshell, 5 to 15 parts by weight of methylsulfonylmethane, 5 to 15 parts by weight of green lipped mussel, 1 to 3 parts by weight of seaweed calcium. , 1 to 3 parts by weight of safflower seeds, 0.5 to 2.5 parts by weight of chitosan oligosaccharides, 3 to 7 parts by weight of spirulina, 1 to 3 parts by weight of liquid minerals, 1 to 3 parts by weight of plant extract, 2 to 4 parts by weight of omega-3 fatty acids. It may be included in a weight ratio of 0.5 to 1.5 parts by weight of colostrum powder, 5 to 15 parts by weight of tapioca starch, 10 to 20 parts by weight of rice bran, and 1 to 5 parts by weight of soybean powder.
기타 실시 예들의 구체적인 사항들은 상세한 설명에 포함되어 있다.Specific details of other embodiments are included in the detailed description.
본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료는 친환경 미래 대체 단백질원인 동애등에와, 농식품 부산물인 아몬드피, 난각 등을 포함함으로써 동애등에, 아몬드피, 난각에 풍부하게 함유되어 있는 단백질, 지방 등의 영양소를 용이하게 섭취하여 가축의 육질을 개선할 수 있고 농식품 부산물의 영양학적 및 사료적 가치를 제고할 수 있다.The mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention contains black soldier flies, which are eco-friendly future alternative protein sources, and almond blood, egg shells, which are agricultural food by-products, and are rich in black soldier flies, almond blood, and egg shells. By easily ingesting nutrients such as protein and fat, the meat quality of livestock can be improved and the nutritional and feed value of agricultural food by-products can be improved.
또한, 본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료는 가축 사육에 필수적인 영양성분이 풍부한 동애등에, 아몬드피, 난각을 포함함으로써 가축의 사료 선호도를 높일 수 있고 영양 성분이 균형있고 풍부하게 함유되어 있어 가축의 건강 및 체중 증가를 향상시킬 수 있다.In addition, the mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention can increase the feed preference of livestock by including black soldier flies, almond blood, and egg shells, which are rich in nutrients essential for livestock breeding, and have nutritional components. Because it is balanced and abundant, it can improve the health and weight gain of livestock.
본 발명의 기술적 사상의 실시예는, 구체적으로 언급되지 않은 다양한 효과를 제공할 수 있다는 것이 충분히 이해될 수 있을 것이다.It will be fully understood that embodiments of the technical idea of the present invention can provide various effects that are not specifically mentioned.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다. 그러나 본 발명은 여기서 설명되는 실시예들에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 실시예들은 개시된 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 발명의 사상이 충분히 전달될 수 있도록 하기 위해 제공되는 것이다.The advantages and features of the present invention, and methods for achieving them, will become clear with reference to the embodiments described in detail below. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, the embodiments introduced herein are provided so that the disclosure will be thorough and complete and so that the spirit of the invention can be sufficiently conveyed to those skilled in the art.
본 출원에서 사용한 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.The terms used in this application are only used to describe specific embodiments and are not intended to limit the invention. Singular expressions include plural expressions unless the context clearly dictates otherwise.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미가 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미가 있는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by a person of ordinary skill in the technical field to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and should not be interpreted as having an ideal or excessively formal meaning unless explicitly defined in the present application. No.
이하, 본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료에 대하여 바람직한 실시예를 들어 상세하게 설명한다.Hereinafter, the mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention will be described in detail with reference to preferred embodiments.
본 발명에 따른 가축용 배합사료는 동애등에, 아몬드피, 난각, 메틸설포닐메탄, 초록입홍합, 해조칼슘, 홍화씨, 키토산올리고당, 스피룰리나(spirulina), 액상미네랄, 식물추출물, 오메가-3 지방산, 초유분말, 타피오카 전분, 미강 및 대두분말을 포함한다.The mixed feed for livestock according to the present invention includes black soldier flies, almond blood, egg shells, methylsulfonylmethane, green-lipped mussels, seaweed calcium, safflower seeds, chitosan oligosaccharides, spirulina, liquid minerals, plant extracts, omega-3 fatty acids, Contains colostrum powder, tapioca starch, rice bran and soybean powder.
또한, 본 발명에 따른 가축용 배합사료는 동애등에 40 내지 60 중량부, 아몬드피 10 내지 20 중량부, 난각 10 내지 20 중량부, 메틸설포닐메탄 5 내지 15 중량부, 초록입홍합 5 내지 15 중량부, 해조칼슘 1 내지 3 중량부, 홍화씨 1 내지 3 중량부, 키토산올리고당 0.5 내지 2.5 중량부, 스피룰리나(spirulina) 3 내지 7 중량부, 액상미네랄 1 내지 3 중량부, 식물추출물 1 내지 3 중량부, 오메가-3 지방산 2 내지 4 중량부, 초유분말 0.5 내지 1.5 중량부, 타피오카 전분 5 내지 15 중량부, 미강 10 내지 20 중량부 및 대두분말 1 내지 5 중량부의 중량 비율로 포함될 수 있다.In addition, the mixed feed for livestock according to the present invention contains 40 to 60 parts by weight of Dongae, etc., 10 to 20 parts by weight of almond blood, 10 to 20 parts by weight of egg shells, 5 to 15 parts by weight of methylsulfonylmethane, and 5 to 15 parts by weight of green lipped mussels. Parts by weight, seaweed calcium 1 to 3 parts by weight, safflower seeds 1 to 3 parts by weight, chitosan oligosaccharide 0.5 to 2.5 parts by weight, spirulina 3 to 7 parts by weight, liquid mineral 1 to 3 parts by weight, plant extract 1 to 3 parts by weight 2 to 4 parts by weight of omega-3 fatty acids, 0.5 to 1.5 parts by weight of colostrum powder, 5 to 15 parts by weight of tapioca starch, 10 to 20 parts by weight of rice bran, and 1 to 5 parts by weight of soybean powder.
상기 동애등에는 절지동물 곤충강 파리목 동애등에과에 속하는 곤충이다. 동애등에는 아르기닌, 메티오닌, 라이신 등과 같은 필수아미노산의 좋은 공급원으로 알려져 있는데, 이러한 아미노산 함량은 일반적으로 대두박보다 높고 어분과 같은 수준으로 알려져 있다. 알려진 바에 따르면 동애등에의 경우 가축이 필요로 하는 주영양소인 단백질 약 40%, 지방 약 20%를 함유하고 있으며, 중쇄 지방산인 라우르 산(Lauric acid)과 불포화 지방산인 올레산(Oleic acid) 및 리놀산(Linoleic acid) 등 가축 사육에 유용한 영양소를 함유하고 있는 것으로 알려져 있다.The black soldier fly is an insect belonging to the arthropod insect class Diptera and the black soldier fly family. Black soldier flies are known to be a good source of essential amino acids such as arginine, methionine, and lysine, and the content of these amino acids is generally known to be higher than that of soybean meal and at the same level as fish meal. It is known that black soldier flies contain about 40% protein and 20% fat, which are the main nutrients required by livestock, and contain medium-chain fatty acid lauric acid and unsaturated fatty acids oleic acid and linoleic acid. It is known to contain nutrients useful for livestock breeding, such as linoleic acid.
예를 들어, 본 발명에서 상기 등애등에는 건조한 후 분말화하여 등애등에 분말의 형태로 사용될 수 있다.For example, in the present invention, the yellow flagellation can be dried and powdered to be used in the form of powder.
상기 아몬드피는 아몬드에서 기름을 짜내고 남은 깻묵일 수 있는데, 상기 아몬드피에는 조단백질, 조섬유, 조지방 등의 함량이 높은데, 이러한 아몬드는 불포화지방산이 풍부하고 비타민 E가 풍부하여 피부 미용에도 좋으며, 철분이나 칼슘도 풍부해 건강에 좋다.The almond skin may be the seed cake left after oil is squeezed out of the almond. The almond skin has a high content of crude protein, crude fiber, and crude fat. These almonds are rich in unsaturated fatty acids and vitamin E, which are good for skin care, and contain iron and calcium. It is also rich in nutrients and good for your health.
상기 난각은 계란 등과 같이 알의 난백과 난황을 사용한 후 폐기되는 농식품 부산물로, 구체적으로 상기 난각(egg-shell)은 동물의 알의 껍질을 의미하는 것으로서, 넓은 의미로는 알을 둘러싸는 맨 바깥층의 딱딱한 층 및 알의 원형질막 바깥쪽의 피막인 난막을 포함한 것들을 의미할 수 있다.The eggshell is an agricultural food by-product that is discarded after using the egg white and yolk, such as eggs. Specifically, the eggshell refers to the shell of an animal egg, and in a broad sense, the outermost layer surrounding the egg. This can mean things including the hard layer of the egg and the egg membrane, which is the outer layer of the egg's plasma membrane.
일반적으로 동물의 알 내부의 내용물을 사용한 뒤 폐기되는 난각에는 잔존하는 내용물과, 난막이 더 포함될 수 있는데, 이때 폐기되는 난각에 잔존하는 내용물은 고농도의 순단백질이고, 난막은 전체 중량의 60wt% 이상이 단백질로 이루어져 있으며, 이외에 조단백질, 철분, 칼슘 등 영양소가 풍부해 사료 원료로 사용될 수 있다.In general, egg shells that are discarded after using the contents of animal eggs may further contain remaining contents and egg membranes. In this case, the remaining contents in the discarded egg shells are high concentrations of pure protein, and the egg membranes contain more than 60 wt% of the total weight. It is made up of this protein and is rich in nutrients such as crude protein, iron, and calcium, so it can be used as a feed ingredient.
상기 메틸설포닐메탄(MSM; Methyl Sulfonyl Methane : Dimethyl Sulfone)은 가축용 배합 사료에 포함되어 관절 및 연골건강에 도움을 줄 수 있는데, 상기 메틸설포닐메탄(MSM)은 비금속 천연유황화합물로서, 식이유황이라고도 불린다. 유황은 필수 영양소이며, 뼈, 연골 등의 결합조직을 최적의 상태로 건강하게 만들어주고, 관절의 활동성을 좋게 해주는 것으로 알려져 있다.The methylsulfonylmethane (MSM; Methyl Sulfonyl Methane: Dimethyl Sulfone) can be included in mixed feed for livestock to help with joint and cartilage health. The methylsulfonylmethane (MSM) is a non-metallic natural sulfur compound and is used in the diet. Also called sulfur. Sulfur is an essential nutrient and is known to keep connective tissues such as bones and cartilage optimally healthy and improve joint activity.
이에 메틸설포닐메탄은 관절 통증의 완화와 관절의 유동성을 개선하는 기능으로 복용되고 있으며, Opti-MSM의 원료로 판매되고 있다. Opti-MSM은 천연펄프에서 추출한 천연유황이다.Accordingly, methylsulfonylmethane is taken to relieve joint pain and improve joint mobility, and is sold as a raw material for Opti-MSM. Opti-MSM is natural sulfur extracted from natural pulp.
상기 메틸설포닐메탄(MSM)은 보통 원산지가 전부 다르며 일반 결정화 정제법으로 추출될 수 있는데, 예를 들어, 본 발명에서 상기 메틸설포닐메탄(MSM)은 미국에서 인증받은 Opti-MSM(Bergstrom Nutrition 사에서 생산)이 바람직하게 사용될 수 있다.The methylsulfonylmethane (MSM) usually has different origins and can be extracted by general crystallization and purification methods. For example, in the present invention, the methylsulfonylmethane (MSM) is obtained from Opti-MSM (Bergstrom Nutrition) certified in the United States. (produced by the company) can be preferably used.
상기 초록입홍합(Perna Canaliculus)은 뉴질랜드 해안에 서식하는 홍합의 일종으로 녹색홍합(Green-lipped Mussel)으로 불리며 학명은 Perna Canaliculus인데, 상기 초록입홍합은 강렬한 자외선에 대항할 수 있도록 진화된 플랑크톤을 주 먹이로 하므로, 다른 지역에서 자생하는 홍합에서는 볼 수 없는 독특한 성분 즉, 항산화와 항염에 관련된 오메가 불포화 지방산을 함유하고 있다고 보고 되었다.The green-lipped mussel (Perna Canaliculus) is a type of mussel that lives on the coast of New Zealand and is called green-lipped mussel. Its scientific name is Perna Canaliculus. The green-lipped mussel produces plankton that has evolved to withstand intense ultraviolet rays. Since it is their main food, it has been reported to contain unique ingredients that cannot be found in mussels growing in other regions, namely omega-unsaturated fatty acids related to antioxidant and anti-inflammatory properties.
또한, 상기 초록입홍합에서 발견된 불포화 지방산은 오메가-3 지방산을 함유하는 물고기 기름, 아마인유, 달맞이 꽃 오일 등보다도 200배 이상의 강한 염증 억제효과가 있는 것으로 임상실험을 통해 알려졌다. 오메가-3계열의 지방산은 오메가-6계열의 리놀레산과 경쟁적으로 작용함으로써 오메가-6 계열 지방산으로부터 만들어지는 염증 매개 물질의 생성을 방해하여 동맥 경화증과 류머티스 관절염 등의 염증성질환 발생을 억제하는 것으로 규명된 바 있다.In addition, it has been known through clinical trials that the unsaturated fatty acids found in the green-lipped mussel have an inflammation-inhibiting effect that is more than 200 times stronger than that of fish oil, linseed oil, and evening primrose oil containing omega-3 fatty acids. Omega-3 fatty acids have been found to inhibit the development of inflammatory diseases such as arteriosclerosis and rheumatoid arthritis by inhibiting the production of inflammatory mediators made from omega-6 fatty acids by competing with omega-6 linoleic acid. There is a bar.
상기 초록입홍합은 하기의 방법으로 제조된 초록입홍합 오일이 사용될 수 있다.The green lipped mussel can be used as green lipped mussel oil prepared by the following method.
먼저, 초록입홍합의 껍질을 제거하고, 상기 껍질이 제거된 초록입홍합을 식물추출물 및 정제수의 혼합액에 침지시킨 후 탄산수소나트륨 용액으로 세척할 수 있다.First, the shell of the green-lipped mussel can be removed, the green-lipped mussel from which the shell has been removed can be immersed in a mixture of plant extract and purified water, and then washed with a sodium bicarbonate solution.
상기 단계에서는 상기 껍질이 제거된 초록입홍합을 10 내지 20℃ 온도 및 1 내지 3(w/w)% 농도 범위를 가지는 탄산수소나트륨 용액으로 세척할 수 있는데, 상기 탄산수소나트륨(NaHCO3)은 식품첨가물로도 이용되는 것으로, 독성이 없으며 침투, 확산, 팽창 등의 기능을 가질 수 있다.In this step, the green-lipped mussel from which the shell has been removed can be washed with a sodium bicarbonate solution having a temperature of 10 to 20°C and a concentration range of 1 to 3 (w/w)%, and the sodium bicarbonate (NaHCO 3 ) is It is also used as a food additive. It is non-toxic and can have functions such as penetration, diffusion, and expansion.
다음으로, 상기 세척된 초록입홍합을 건조할 수 있다.Next, the washed green lipped mussels can be dried.
상기 세척된 초록입홍합의 건조는 제1 건조 및 제2 건조로 이루어질 수 있는데, 상기 제1 건조는 상기 세척된 초록입홍합을 70 내지 80℃의 온도에서 3 내지 5시간 동안 건조시켜 상기 세척된 초록입홍합에 잔류하는 수분을 1차로 제거할 수 있다.Drying of the washed green-lipped mussels may be accomplished by first drying and second drying. The first drying is performed by drying the washed green-lipped mussels at a temperature of 70 to 80° C. for 3 to 5 hours to dry the washed green-lipped mussels. The remaining moisture in the green-lipped mussel can be removed first.
또한, 상기 제2 건조는 상기 제1 건조된 초록입홍합을 열풍으로 건조할 수 있는데, 상기 제2 건조는 상기 제1 건조된 초록입홍합을 110 내지 130℃ 온도의 열풍을 1 내지 3시간 동안 가하여 줌으로써 수행될 수 있다.In addition, the second drying may be performed by drying the first dried green-lipped mussels with hot air. In the second drying, the first dried green-lipped mussels may be dried with hot air at a temperature of 110 to 130° C. for 1 to 3 hours. It can be done by giving.
그 다음으로, 상기 제2 건조된 초록입홍합을 분쇄하여 분말화한 후 숙성하여 초록입홍합 숙성분말을 제조할 수 있다.Next, the second dried green-lipped mussel can be pulverized, powdered, and then aged to produce aged green-lipped mussel powder.
상기 단계에서 상기 제2 건조된 초록입홍합의 분쇄는 상기 제2 건조된 초록입홍합을 5 내지 10mm의 입경으로 분쇄하여 분말화하고, 상기 분말화된 초록입홍합의 숙성은 상기 분말화된 초록입홍합을 5 내지 10℃의 온도에서 3 내지 7시간 동안 보관함으로써 수행될 수 있다.In the above step, the second dried green-lipped mussels are pulverized into powder by pulverizing the second dried green-lipped mussels to a particle size of 5 to 10 mm, and the maturation of the powdered green-lipped mussels is performed by pulverizing the second dried green-lipped mussels into a particle size of 5 to 10 mm. This can be done by storing the lipped mussels at a temperature of 5 to 10°C for 3 to 7 hours.
이어서, 상기 초록입홍합 숙성분말에 효소와 산을 혼합한 후 보관하여 효소 분해할 수 있다.Subsequently, the green lipped mussel aged powder can be mixed with enzyme and acid and then stored for enzymatic decomposition.
즉, 상기 단계에서는 상기 초록입홍합 숙성분말에 효소와 산을 혼합한 후 상기 효소 및 산이 혼합된 초록입홍합 숙성분말을 36 내지 38℃의 온도에서 20 내지 30시간 동안 보관함으로써 효소 분해할 수 있다.That is, in the above step, enzyme and acid are mixed with the green lipped mussel ripening powder, and then the green lipped mussel ripening powder mixed with the enzyme and acid is stored at a temperature of 36 to 38 ° C. for 20 to 30 hours to enzymatically decompose. .
상기 단계에서 상기 효소로는 시중에 판매되고 있는 공지된 프로테아제(Protease), 키티나제(chitinase), 펙티나제(Pectinase) 및 자일라나제(Xylanase)가 이용되고, 상기 산으로는 구연산 및 아스코르빈산이 이용될 수 있는데, 구체적으로는 상기 초록입홍합 숙성분말 전체 100 중량부에 대해 상기 프로테아제(Protease) 0.01 내지 0.03 중량부, 키티나제(chitinase) 0.03 내지 0.05 중량부, 펙티나제(Pectinase) 0.005 내지 0.009 중량부, 자일라나제(Xylanase) 0.008 내지 0.012 중량부, 구연산 0.01 내지 0.1 중량부 및 아스코르빈산 0.01 내지 0.1 중량부의 중량 비율로 혼합할 수 있다. In this step, commercially known protease, chitinase, pectinase, and xylanase are used as the enzymes, and citric acid and ascorbic acid are used as the acids. Bic acid may be used, specifically, 0.01 to 0.03 parts by weight of the protease, 0.03 to 0.05 parts by weight of chitinase, and pectinase for 100 parts by weight of the green lipped mussel ripened powder. It can be mixed in a weight ratio of 0.005 to 0.009 parts by weight, 0.008 to 0.012 parts by weight of xylanase, 0.01 to 0.1 parts by weight of citric acid, and 0.01 to 0.1 parts by weight of ascorbic acid.
다음으로, 상기 효소 분해된 초록입홍합 숙성분말에 유산균 배양액을 혼합한 후 발효하여 초록입홍합 발효물을 제조할 수 있다.Next, the fermented green-lipped mussel product can be produced by mixing the enzymatically decomposed green-lipped mussel mature powder with lactic acid bacteria culture and then fermenting it.
상기 단계에서는 효소 분해된 초록입홍합 숙성분말 100 중량부에 대해 유산균 배양액 1 내지 3 중량부의 중량 비율로 혼합한 후, 40 내지 42℃의 온도에서 20 내지 30시간 동안 발효함으로써 진행될 수 있다.In this step, it can be carried out by mixing 1 to 3 parts by weight of lactic acid bacteria culture medium with respect to 100 parts by weight of enzymatically decomposed green lipped mussel mature powder, and then fermenting at a temperature of 40 to 42 ° C. for 20 to 30 hours.
또한, 상기 단계에서 상기 유산균 배양액은, 1.2N HCl을 이용하여 배지의 pH를 2.8~3.2로 조정한 다음 김치로부터 유산 균주를 분리하고, 상기 분리된 유산 균주를 MRS broth(Oxoid, England)를 이용하여 37~39℃에서 20 내지 25시간 동안 배양한 후 1×1.08 ~ 5×1.08 CFU/mL이 되도록 희석하며, 이후 10,000 내지 15,000rpm에서 10~15분간 원심분리하여 상청액(supernatant)만을 분리하고, 상기 상청액(Supernatant)을 0.45㎛ 시린지 필터(syringe filter)로 여과 후, 상기 여과된 상청액 100 중량부에 대해 멸균한 증류수 1,000 내지 2,000 중량부의 중량 비율로 혼합하여 희석함으로써 제조되고, 상기 유산균은 발효 식품인 김치로부터 분리된 유산 균주로, 구체적으로, 상기 유산 균주로는 락토바실러스 쿠르바투스(Lactobacillus curvatus), 바이셀라 비리데센스(Weissella viridescens), 락토바실러스 플란타럼(Lactobacillus plantarum) 및 류코노스톡 락티스(Leuconostoc lactis)로 이루어진 군에서 선택된 어느 하나 이상의 공지된 유산 균주가 사용될 수 있다.In addition, in the above step, the pH of the lactic acid bacteria culture medium was adjusted to 2.8 to 3.2 using 1.2N HCl, then the lactic acid strain was isolated from kimchi, and the isolated lactic acid strain was cultured using MRS broth (Oxoid, England). After culturing at 37 to 39°C for 20 to 25 hours, it was diluted to 1×1.0 8 to 5×1.0 8 CFU/mL, and then centrifuged at 10,000 to 15,000 rpm for 10 to 15 minutes to separate only the supernatant. The supernatant is filtered through a 0.45㎛ syringe filter and then diluted by mixing with 1,000 to 2,000 parts by weight of sterilized distilled water for 100 parts by weight of the filtered supernatant, and the lactic acid bacteria are A lactic acid strain isolated from kimchi, a fermented food. Specifically, the lactic acid strain includes Lactobacillus curvatus , Weissella viridescens , Lactobacillus plantarum , and Any one or more known lactic acid strains selected from the group consisting of Leuconostoc lactis may be used.
그 다음으로, 상기 초록입홍합 발효물을 이용하여 오일을 분리함으로써 초록입홍합 오일을 제조할 수 있다.Next, green lipped mussel oil can be produced by separating the oil using the green lipped mussel fermentation product.
상기 단계에서 상기 초록입홍합 발효물을 이용하여 오일을 분리하는 등의 구성은 당해 기술 분야에서 통상의 지식을 가진 자에게는 공지의 기술인 바, 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.In the above step, the composition of separating the oil using the green lipped mussel fermentation product is a known technique to those skilled in the art, so for convenience of explanation and clarity of the technical idea of the present invention, this is done. Detailed explanation will be omitted.
상기 해조칼슘의 원료인 해조는 홍조류로 분류되며, 청정해역에서 자라는 식용식물로서 엽록소 외에 붉은 색소를 가지고 있는 꼬시래기, 김, 풀가사리, 우뭇가사리류 등이 있다. 각종 영양물질과 미네랄을 흡수하여 줄기에 95~99%의 칼슘을 함유하며 이를 수확하여 가공한 것이 해조칼슘이다.Seaweed, which is the raw material for the seaweed calcium, is classified as red algae, and is an edible plant that grows in clean sea areas and includes seaweed, seaweed, agar, agar, etc., which have red pigment in addition to chlorophyll. It absorbs various nutrients and minerals and contains 95-99% of calcium in the stem. Seaweed calcium is harvested and processed.
상기 해조칼슘의 칼슘함량은 34% 이상이며 칼슘흡수에 방해되는 섬유질이나 피틴산이 없고 마그네슘 2.4% 외에 칼륨 0.7%, 황 0.67%, 인 0.08%, 철 915ppm, 망간 125ppm, 아연 26.1ppm, 셀레늄 1ppm등 생리활성에 기여하는 여러 종의 미량 성분을 함유하고 있다.The calcium content of the seaweed calcium is more than 34%, and there is no fiber or phytic acid that interferes with calcium absorption. In addition to 2.4% magnesium, it contains 0.7% potassium, 0.67% sulfur, 0.08% phosphorus, 915 ppm iron, 125 ppm manganese, 26.1 ppm zinc, 1 ppm selenium, etc. It contains several types of trace elements that contribute to physiological activity.
상기 홍화씨는 불포화지방산인 리놀산(linoleicacid)과 칼륨, 칼슘, 마그네슘, 금, 알루미늄, 브롬, 구리, 철, 망간, 루비듐, 아연 등의 광물질 원소인 무기물질과 카르타민, 칼콘산 배당체 등의 성분이 함유되어 있고, 특히, 홍화새싹에는 황산화 물질인 루테올린성분이 다량으로 함유되어 있어 우리몸에 신진대사를 촉진시키거나 각종 질병을 치료하는 약효가 있는 것으로 밝혀지면서 폭발적으로 소비가 늘고 있다.The safflower seeds contain linoleic acid, an unsaturated fatty acid, inorganic substances such as potassium, calcium, magnesium, gold, aluminum, bromine, copper, iron, manganese, rubidium, and zinc, and components such as cartamin and chalconic acid glycosides. In particular, safflower sprouts contain a large amount of luteolin, a sulfated substance, and as it has been found to have medicinal properties in promoting metabolism in our body and treating various diseases, its consumption is increasing explosively.
상기 키토산올리고당은 설사를 유발하는 대장균이나 살모넬라 등 그람 음성균에 항균력을 가지고 있으며, 이는 키토산의 양이온성 아민기가 미생물 세포벽의 음이온성 카르복실기와 반응함으로써 병원성 미생물의 활동을 억제하는 작용을 하기 때문이다. 키토산올리고당은 또한 면역체계에 있는 T-세포(T-cell), 대식세포(Macrophage) 및 자연살해세포(Natural killer cell) 등을 활성화시킴으로써 가축 체내 면역력을 증진시키는 효과가 있다.The chitosan oligosaccharide has antibacterial activity against Gram-negative bacteria such as Escherichia coli and Salmonella that cause diarrhea, and this is because the cationic amine group of chitosan reacts with the anionic carboxyl group of the microbial cell wall to inhibit the activity of pathogenic microorganisms. Chitosan oligosaccharides also have the effect of improving immunity in livestock by activating T-cells, macrophages, and natural killer cells in the immune system.
또한, 미생물에 의해 최종적으로 생산된 글루코사민의 경우는 항생물질의 전구체로 사용되며, 생변환에 의한 단백질의 생산, 그 외 식품분야 및 의약품분야에서 널리 이용되고 있다.In addition, glucosamine, which is ultimately produced by microorganisms, is used as a precursor for antibiotics and is widely used in the production of proteins through biotransformation and in other food and pharmaceutical fields.
일반적으로 키토산(Chitosan)은 탈아세틸화 반응을 거쳐 키틴으로부터 얻어지는 폴리머로서, 키틴의 거대분자가 저분자화된 형태라고 할 수 있다. 키토산은 염산, 질산 등과 같은 무기산 및 초산, 젖산, 아스코빈산, 사과산 등과 같은 유기산의 묽은 산성 용액에 용해되며 반응성이 풍부한 유리 아미노기를 가지고 있어 콜레스테롤 저하, 면역증강, 혈압강하, 간 기능 개선, 혈당저하, 항균성 등의 생리활성이 있어 식품, 화장품, 의약품, 농,축,수산 분야에 다양하게 응용되고 있다.In general, chitosan is a polymer obtained from chitin through a deacetylation reaction, and can be said to be a low-molecular form of the macromolecule of chitin. Chitosan is soluble in dilute acidic solutions of inorganic acids such as hydrochloric acid, nitric acid, and organic acids such as acetic acid, lactic acid, ascorbic acid, and malic acid, and has highly reactive free amino groups, which lowers cholesterol, enhances immunity, lowers blood pressure, improves liver function, and lowers blood sugar. It has biological activities such as antibacterial properties and is used in a variety of fields such as food, cosmetics, pharmaceuticals, agriculture, livestock, and fisheries.
이렇게 만들어진 키토산은 물, 알코올 용매에는 녹지 않으며 약산에 녹는 특성을 갖고 있으며, 무공해 및 무독성의 생분해성 물질이다. 한편 분자량이 10만~20만인 키토산을 다시 한 번 저분자화하여 글루코사민(Glucosamine) 2~10개까지 분해한 것을 키토산 올리고당(Chito-oligosaccharide)이라고 한다.Chitosan produced in this way is insoluble in water and alcohol solvents, has the property of dissolving in weak acids, and is a non-polluting and non-toxic biodegradable material. Meanwhile, chitosan, which has a molecular weight of 100,000 to 200,000, is once again reduced to a low molecular weight and decomposed into 2 to 10 glucosamines, and is called chito-oligosaccharide.
상기 스피룰리나(spirulina)는 가축용 배합사료에 포함되어 활성산소를 제거해 노화를 방지하고, 노폐물 배출에 도움을 주며 장내 유익균의 성장을 도와 장 환경 개선에 도움을 줄 수 있다.The spirulina is included in mixed feed for livestock and can help prevent aging by removing active oxygen, help excrete waste products, and improve the intestinal environment by helping the growth of beneficial bacteria in the intestines.
상기 스피룰리나(spirulina)는 남조류의 나선형 다세포 미생물로, 엽록소, 피코시안 색소가 있어 광합성을 하는데, 에티오피아가 원산이며, 단백질 함유량이 60% 이상으로 클로렐라 등과 함께 미래의 단백질원으로 주목되고 있다. 현재 약 30종이 알려져 있으며, 열대 지방의 염호(鹽湖)에 자생한다. 스피룰리나는 사이아노박테리아의 일종으로 해수와 염도가 높고 강한 알칼리성을 지닌 열대지방의 더운 물에서 번식하며, 식물과 동물의 혼합 형태이다.Spirulina is a spiral-shaped multicellular microorganism of blue-green algae that photosynthesizes because it contains chlorophyll and picocyanin pigments. It is native to Ethiopia and has a protein content of over 60%, so it is attracting attention as a future protein source along with chlorella. Currently, about 30 species are known, and they grow naturally in salt lakes in tropical regions. Spirulina is a type of cyanobacteria that grows in seawater and hot water in tropical regions with high salinity and strong alkalinity, and is a mixture of plants and animals.
상기 스피룰리나의 구성 성분은 단백질 60~70%, 지질 6~9%, 탄수화물 15~20%로 이루어져 있으며, 비타민, 무기질, 섬유소 등을 함유하고 있고, 카로티노이드, 클로로필, 피코시안 등의 색소가 들어 있다. 필수아미노산을 모두 함유하고 있으며, 필수지방산인 리놀렌산, 감마리놀렌산도 풍부하고, 소화 흡수율이 95% 이상으로 소화가 잘 되는 것이 장점이다.The composition of the spirulina consists of 60-70% protein, 6-9% lipid, and 15-20% carbohydrate, and contains vitamins, minerals, fiber, etc., and pigments such as carotenoid, chlorophyll, and phycocyan. . It contains all essential amino acids, is rich in essential fatty acids linolenic acid and gamma-linolenic acid, and has the advantage of being easily digested with a digestion and absorption rate of over 95%.
상기 스피룰리나는 건강식품으로서의 안전성과 완전식품으로서의 영양적 가치는 국제연합(UN), 세계보건기구(WHO), 미국식품의약국(FDA) 등에서도 공식 인정받고 있으며, 미국항공우주국(NASA)에 의해 우주인들의 비상식량으로 결정되기도 하였다. 영양학적인 가치, 건강식품으로서의 유용성 외에도 스피룰리나의 항암효과, 각종 면역 기능 증강 효과, 기능성 화장품 소재로서의 가능성 등도 연구 보고되고 있다.The safety of the spirulina as a health food and its nutritional value as a complete food are officially recognized by the United Nations (UN), the World Health Organization (WHO), and the U.S. Food and Drug Administration (FDA), and by the National Aeronautics and Space Administration (NASA). It was also chosen as emergency food for astronauts. In addition to its nutritional value and usefulness as a health food, spirulina's anticancer effect, various immune function enhancing effects, and its potential as a functional cosmetic material are also being reported.
상기 액상미네랄은 하기의 방법으로 제조된 액상미네랄이 사용될 수 있다.The liquid mineral may be a liquid mineral prepared by the following method.
상기 액상미네랄을 제조하기 위하여, 먼저, 해수를 수집할 수 있다.To produce the liquid mineral, first, seawater can be collected.
상디 단계에서 상기 해수로는 해양 심층수를 사용할 수 있는데, 상기 해양 심층수(海洋深層水)는 통상 200m 이하의 해수(海水)를 해양 심층수라고 부르며, 표층해수와는 달리 햇빛이 닿지 않아 플랑크톤(Plankton) 및 생명체가 증식하지 못하기 때문에 영양염류의 농도가 높으면서 수온에 따른 밀도차이로 표층해수와 혼합되지 않아 표층해수에 존재하는 오염물질이 없으며, 표층해수와 비교하였을 때 저온안정성, 오염물질, 유해세균이나 유기물이 매우 적은 청정성, 식물의 생장에 매우 중요한 무기영양염류가 풍부한 부영양성과 다양한 미네랄성분이 균형있게 존재하는 미네랄밸런스(Mineral balance) 특성과 고압 저온상태에서 긴 세월동안 물 분자의 집단(Cluster)이 소집단화 되어 표면장력이 적으면서 침투성이 좋은 물로 숙성된 숙성성 등의 특성이 있다.In the Sangji stage, deep ocean water can be used as the seawater. The deep ocean water is usually seawater below 200m and is called deep ocean water. Unlike surface seawater, sunlight does not reach, so plankton forms. And because living organisms cannot proliferate, the concentration of nutrients is high and they do not mix with surface seawater due to density differences depending on water temperature, so there are no contaminants present in surface seawater. Compared to surface seawater, low-temperature stability, pollutants, and harmful bacteria are eliminated. Cleanliness with very little organic matter, eutrophication rich in inorganic nutrients that are very important for plant growth, and mineral balance characteristics with a balanced presence of various mineral components, and clustering of water molecules over a long period of time under high pressure and low temperature conditions. ) is subgrouped and has characteristics such as ripening ability with water that has low surface tension and good permeability.
특히, 해양 심층수에서 생산된 미네랄 성분이 다량 함유된 소금은, 호염성 발효미생물의 생육에 필요한 칼슘(Ca), 마그네슘(Mg), 철(Fe), 아연(Zn)과 같은 다종다양한 미네랄 성분이 함유되어 있으며, 특히 햇빛이 닿지 않으면서 저온으로 생물이 살지 않아 질산염, 인산염, 규산염과 같은 영양염류의 농도가 높으면서, 오염된 표층해수와는 밀도차이로 전혀 섞이지 않아 오염물질이 함유되어 있지 않은 특성이 있다.In particular, salt containing a large amount of mineral components produced in deep ocean water contains a variety of mineral components such as calcium (Ca), magnesium (Mg), iron (Fe), and zinc (Zn) necessary for the growth of halophilic fermentation microorganisms. In particular, it has a high concentration of nutrients such as nitrates, phosphates, and silicates as living things do not survive due to the low temperature and lack of exposure to sunlight, but does not mix with polluted surface seawater at all due to the difference in density, so it does not contain pollutants. There is.
다음으로, 상기 수집된 해수를 제1 건조하고, 상기 제1 건조 후 침전된 이물질이나 고형물을 필터를 이용하여 분리하여 제거함으로써 제1 해수를 제조할 수 있다.Next, the first seawater can be produced by first drying the collected seawater, and separating and removing foreign substances or solids precipitated after the first drying using a filter.
상기 해수의 제1 건조는 상기 수집된 해수를 20 내지 40℃의 온도에서 10 내지 20일 동안 방치하여 자연 건조함으로써 처음 수집된 해수 질량의 1/5 내지 2/5가 증발될 때까지 진행될 수 있는데, 상기 제1 건조 후 침전된 이물질이나 생성된 소금 결정을 제거하고 액체의 해수만을 수집함으로써 제1 해수를 얻을 수 있다.The first drying of the seawater may be carried out by naturally drying the collected seawater by leaving it at a temperature of 20 to 40°C for 10 to 20 days until 1/5 to 2/5 of the mass of the seawater initially collected is evaporated. , the first seawater can be obtained by removing precipitated foreign substances or salt crystals formed after the first drying and collecting only liquid seawater.
그 다음으로, 상기 제1 해수에 활성탄 및 순지트 분말을 혼합한 후 제2 건조하고, 상기 제2 건조 후 침전된 이물질이나 고형물과 활성탄 및 순지트 분말을 필터를 이용하여 분리하여 제거함으로써 제2 해수를 제조할 수 있다.Next, activated carbon and shungite powder are mixed with the first seawater, followed by second drying, and the foreign matter or solid matter precipitated after the second drying and the activated carbon and shungite powder are separated and removed using a filter. Seawater can be manufactured.
상기 제1 해수의 제2 건조에서 상기 활성탄은 유해물질의 흡착제거 효과를 구현할 수 있고, 상기 순지트 분말은 항산화, 살균, 오염물질의 안정화 및 분해 기능 등을 수행할 수 있는데, 상기 제1 해수의 제2 건조는 상기 제1 해수 100 중량부에 대해 활성탄 1 내지 3 중량부 및 순지트 분말 0.1 내지 0.5 중량부의 중량 비율로 혼합한 후 20 내지 40℃의 온도에서 1 내지 5일 동안 건조함으로써 진행될 수 있다.In the second drying of the first seawater, the activated carbon can implement the effect of adsorbing and removing harmful substances, and the shungite powder can perform antioxidant, sterilizing, stabilizing and decomposing functions of pollutants, etc. The second drying is carried out by mixing 1 to 3 parts by weight of activated carbon and 0.1 to 0.5 parts by weight of shungite powder with respect to 100 parts by weight of the first seawater and then drying at a temperature of 20 to 40 ° C. for 1 to 5 days. You can.
상기 제1 해수의 제2 건조에서 상기 활성탄은 미세세공이 발달된 탄소집합체로서, 활성화과정에 의해 내부 표면적을 변화시킬 수 있으며, 내부의 탄소 원자 관능 기에 의해 주위 액체 또는 기체와 흡착이 이루어지는 흡수성과 흡착성이 우수한 성질을 갖는다.In the second drying of the first seawater, the activated carbon is a carbon aggregate with developed micropores, and can change the internal surface area through the activation process, and has an absorbency and adsorption with surrounding liquid or gas by the internal carbon atom functional group. It has excellent adsorption properties.
상기 활성탄은 유해물질의 흡착제거 효과를 구현할 수 있는데, 상기 활성탄은 경도 93 질량분율% 이상, 충전밀도 0.51 내지 0.53g/ml, 비표면적 800 내지 900m2/g, 세공분포는 세공직경이 4Å 내지 7Å, 요오드 흡착력 1,100mg/g 이상, 세공용적 0.51ml/g, pH 7~7.8, 페놀 흡착력 17.5ml/g, M·B 탈색력 153ml/g 이상인 것이 사용될 수 있다.The activated carbon can realize the effect of adsorption and removal of harmful substances. The activated carbon has a hardness of 93% by mass or more, a packing density of 0.51 to 0.53g/ml, a specific surface area of 800 to 900m 2 /g, and a pore distribution with a pore diameter of 4Å to 4Å. 7Å, iodine adsorption capacity of 1,100 mg/g or more, pore volume of 0.51 ml/g, pH 7-7.8, phenol adsorption power of 17.5 ml/g, and M·B decolorization power of 153 ml/g or more can be used.
상기 순지트 분말은 순지트 광물을 분쇄하여 분말화함으로써 제조될 수 있는데, 상기 순지트(shungite)는 SiO2(규산염)과 C60(플러렌)을 주성분으로 하는 물질로서, 천연 플러렌을 함유하는 물질을 의미한다. 플러렌을 90% 이상 함유한 순지트를 엘리트 순지트(Elite shungite) 또는 노블 순지트(Noble Shungite)라 하고, 플러렌을 60% 이하 함유한 순지트를 노멀 순지트(Normal shungite)라 한다.The shungite powder can be manufactured by pulverizing the shungite mineral. The shungite is a material containing SiO 2 (silicate) and C 60 (fullerene) as main components, and contains natural fullerene. means. Shungite containing more than 90% fullerene is called elite shungite or noble shungite, and shungite containing less than 60% fullerene is called normal shungite.
상기 순지트의 대표적인 기능은 항산화 기능, 전자파 차단 기능, 오염물질의 정화 및 분해 기능, 그리고 살균 및 항균 기능이 있다. 순지트는 강력한 천연산화방지제로서 수많은 질병에 대한 인간의 면역성을 높여주는 기능이 있고, 오염물질을 흡착시켜 물과 공기를 정화시키는 기능을 하며, 흡착한 오염물질을 스스로 분해하는 능력이 있다.Representative functions of the shungite include antioxidant function, electromagnetic wave blocking function, purification and decomposition function of pollutants, and sterilization and antibacterial function. Sunjit is a powerful natural antioxidant that has the function of increasing human immunity against numerous diseases, has the function of purifying water and air by adsorbing pollutants, and has the ability to decompose adsorbed pollutants on its own.
또한, 상기 순지트는 항균 및 살균 성질을 가지고 있어 대장균, 녹농균, 포도상구균 및 유해균만을 99% 이상 제거하는 기능이 있고, 유해전자파를 차단하고, 원적외선을 다량 방출하는 기능이 있다.In addition, the shungite has antibacterial and sterilizing properties and has the function of removing more than 99% of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and harmful bacteria, blocking harmful electromagnetic waves, and emitting a large amount of far-infrared rays.
상기 순지트 분말은 하기의 방법으로 제조된 순지트 분말이 사용될 수 있다.The Sungite powder may be used as the Sungite powder prepared by the following method.
먼저, 순지트 광물을 준비한 후 세척하여 상기 순지트 광물에 부착되어 있는 이물질을 제거할 수 있다.First, the shungite mineral can be prepared and then washed to remove foreign substances attached to the shungite mineral.
상기 순지트 광물의 세척은 정제수를 이용하여 상기 순지트 광물의 표면을 세척함으로써, 상기 순지트 광물의 표면에 잔류되어 있는 이물질을 제거할 수 있다.Cleaning of the shungite mineral can be performed by washing the surface of the shungite mineral using purified water to remove foreign substances remaining on the surface of the shungite mineral.
다음으로, 상기 세척된 순지트 광물을 제1 분쇄하여 순지트 조립 분쇄물을 제조할 수 있다.Next, the washed shungite mineral may be first pulverized to produce a shungite granulated pulverized product.
상기 단계에서는 상기 세척된 순지트 광물을 조립기를 이용하여 제1 분쇄함으로써, 추후 공정에서 상기 순지트 광물의 불순물이나 유기 잔류물 등을 제거할 수 있는데, 상기 제1 분쇄는 그래뉼레이터(pan granulator), 드럼 그래뉼레이터(Drum granulator) 또는 압축식 펠레타이저(pelletizer) 등과 같은 공지된 조립기를 이용하여 수행될 수 있으나, 반드시 상기한 조립기에만 한정되는 것은 아니다.In this step, the washed shungite mineral is first pulverized using a granulator to remove impurities or organic residues of the shungite mineral in a later process. The first pulverization is performed using a granulator (pan granulator). , It can be performed using a known granulator such as a drum granulator or a compression pelletizer, but is not necessarily limited to the above-mentioned granulator.
그 다음으로, 상기 순지트 조립 분쇄물을 혼합액에 침지할 수 있다.Next, the shungite granulated pulverized product can be immersed in the mixed solution.
상기 단계에서는 상기 순지트 조립 분쇄물을 혼합액에 침지함으로써 상기 순지트 조립 분쇄물에 함유되어 있는 불순물이나 유기 잔류물 등을 제거할 수 있는데, 상기 혼합액으로는 질산 0.2 내지 0.4 중량%, 인산염 화합물 0.5 내지 1.0 중량%, 과황산염 0.01 내지 0.05 중량%, 초산 1 내지 3 중량% 및 잔량의 정제수로 이루어지고, 상기 순지트 조립 분쇄물을 20 내지 40분 동안 상기 혼합액에 침지시켜 수행될 수 있다.In the above step, impurities or organic residues contained in the granulated shungite product can be removed by immersing the granulated shungite product in a mixed solution, which includes 0.2 to 0.4% by weight of nitric acid and 0.5% by weight of a phosphate compound. to 1.0% by weight, 0.01 to 0.05% by weight of persulfate, 1 to 3% by weight of acetic acid, and the remaining amount of purified water, and can be performed by immersing the granulated shungite powder in the mixed solution for 20 to 40 minutes.
또한, 상기 단계에서 상기 인산염 화합물로는 제1 인산나트륨(NaH2PO4), 제2 인산나트륨(Na2HPO4), 제3 인산나트륨(Na3PO4), 제1 인산칼륨(KH2PO4), 제2 인산칼륨(K2HPO4), 제1 인산암모늄((NH4)H2PO4), 제2 인산암모늄((NH4)2HPO4) 및 제3 인산암모늄((NH4)3PO4)으로 이루어진 군에서 선택되는 어느 하나 이상이 사용될 수 있고, 상기 과황산염으로는 과황산암모늄((NH4)2S2O8), 과황산나트륨(Na2S2O8) 또는 과황산칼륨(K2O8S2) 중에서 선택된 어느 하나 이상이 사용될 수 있다.In addition, in the above step, the phosphate compounds include monobasic sodium phosphate (NaH 2 PO 4 ), dibasic sodium phosphate (Na 2 HPO 4 ), tribasic sodium phosphate (Na 3 PO 4 ), and potassium monobasic phosphate (KH 2 PO 4 ), potassium dibasic phosphate (K 2 HPO 4 ), ammonium monobasic phosphate ((NH 4 )H 2 PO 4 ), ammonium dibasic phosphate ((NH 4 ) 2 HPO 4 ) and ammonium tertiary phosphate (( NH 4 ) 3 PO 4 ) Any one or more selected from the group consisting of may be used, and the persulfate includes ammonium persulfate ((NH 4 ) 2 S 2 O 8 ) and sodium persulfate (Na 2 S 2 O 8 ) or potassium persulfate (K 2 O 8 S 2 ) may be used.
이어서, 상기 순지트 조립 분쇄물을 혼합액에서 분리하여 꺼낸 후 상기 순지트 조립 분쇄물을 소성로를 이용하여 가열하여 소성할 수 있다.Subsequently, the granulated shungite pulverized product can be separated and taken out from the mixed liquid, and then the granulated shungite pulverized product can be heated and fired using a sintering furnace.
상기 단계에서는 상기 분리된 순지트 조립 분쇄물을 소성로를 이용하여 가열함으로써 상기 순지트 조립 분쇄물의 미세 기공에 흡착된 오염물질을 제거하고 활성화시킬 수 있는데, 상기 단계는 상기 분리된 순지트 조립 분쇄물을 소성로에 투입한 후 1,100 내지 1,300℃의 온도에서 50 내지 100분 동안 가열함으로써 수행될 수 있다.In the step, contaminants adsorbed on the micropores of the granulated shungite can be removed and activated by heating the separated granulated shungite using a calcination furnace. It can be performed by putting it into a kiln and heating it at a temperature of 1,100 to 1,300°C for 50 to 100 minutes.
다음으로, 상기 소성된 순지트 조립 분쇄물을 제2 분쇄하여 순지트 미립 분쇄물을 제조할 수 있다.Next, the calcined shungite granulated pulverized product may be subjected to a second pulverization to produce fine shungite pulverized product.
상기 단계에서는 상기 소성된 순지트 조립 분쇄물을 볼밀(ball mill)이나 각종 공지된 분쇄기를 이용하여 분쇄함으로써 수행될 수 있는데, 상기 단계에서는 제조되는 패각 미립 분쇄물의 입경이 10 내지 100nm가 되도록 분쇄할 수 있다.The step can be performed by pulverizing the calcined shungite granulated product using a ball mill or various known grinders. In this step, the produced shell fine pulverized product is pulverized so that the particle size is 10 to 100 nm. You can.
그 다음으로, 상기 순지트 미립 분쇄물에서 불순물을 제거하고 살균하여 순지트 분말을 제조할 수 있다.Next, impurities can be removed from the pulverized Sungite fine particles and sterilized to produce Sungite powder.
상기 단계에서는 상기 순지트 미립 분쇄물을 자석이 설치된 회전통에서 회전시킴으로써 상기 순지트 미립 분쇄물에 잔류할 수 있는 중금속 등과 같은 불순물을 제거할 수 있는데, 구체적으로는 상기 순지트 미립 분쇄물을 자석이 설치된 회전통에 투입한 후 500 내지 1000RPM의 회전속도로 10 내지 20분 동안 회전시킴으로써 상기 순지트 미립 분쇄물에 포함될 수 있는 중금속 등과 같은 불순물을 제거할 수 있다.In the above step, impurities such as heavy metals that may remain in the pulverized Shungite fines can be removed by rotating the pulverized Shungite fines in a rotary drum installed with a magnet. Specifically, the pulverized Shungite fines can be removed using a magnet. After being placed in this installed rotary drum, impurities such as heavy metals that may be included in the pulverized shungite fine particles can be removed by rotating it at a rotation speed of 500 to 1000 RPM for 10 to 20 minutes.
이어서, 상기 제2 해수에 미세 다공체를 혼합한 후 제1 가열하여 수분을 증발시키고 필터를 이용하여 액체만을 분리하여 수집함으로써 제3 해수를 제조할 수 있다.Subsequently, a third seawater can be produced by mixing a microporous body with the second seawater, evaporating moisture through first heating, and separating and collecting only the liquid using a filter.
상기 단계에서는 상기 제2 해수에 미세 다공체를 혼합한 후 가열함으로써 상기 제2 해수에 함유되어 있는 황산칼슘(CaSO4)과 염화나트륨(NaCl) 성분이 먼저 석출될 수 있는데, 상기 미세 다공체는 상기 제2 해수가 급격하게 가열되는 것을 방지하고 생성된 황산칼슘(CaSO4)과 염화나트륨(NaCl) 성분이 상기 미세 다공체 표면에 용이하게 포집되도록 할 수 있다.In this step, the calcium sulfate (CaSO 4 ) and sodium chloride (NaCl) components contained in the second seawater may be precipitated first by mixing the microporous body with the second seawater and then heating it. It is possible to prevent seawater from being rapidly heated and to ensure that the generated calcium sulfate (CaSO 4 ) and sodium chloride (NaCl) components are easily collected on the surface of the microporous body.
상기 단계에서는 상기 제2 해수 100 중량부에 대해 미세 다공체 1 내지 5 중량부의 중량 비율로 혼합한 후 80 내지 85℃의 온도에서 5 내지 10시간 동안 가열하여 수분을 증발시킴으로써 상기 제2 해수에 함유되어 있는 황산칼슘(CaSO4)과 염화나트륨(NaCl) 성분이 석출되도록 하고, 상기 황산칼슘(CaSO4)과 염화나트륨(NaCl) 성분이 석출되고 남은 해수를 분리함으로써 미네랄 성분이 농축되어 있는 제3 해수를 제조할 수 있다.In this step, 100 parts by weight of the second seawater are mixed at a weight ratio of 1 to 5 parts by weight of the microporous material, and then heated at a temperature of 80 to 85 ° C. for 5 to 10 hours to evaporate the moisture, so that it is contained in the second seawater. The calcium sulfate (CaSO 4 ) and sodium chloride (NaCl) components are allowed to precipitate, and the seawater remaining after the calcium sulfate (CaSO 4 ) and sodium chloride (NaCl) components are precipitated is separated to produce a third seawater with concentrated mineral components. can do.
상기 미세 다공체는 하기의 방법으로 제조된 미세 다공체가 사용될 수 있다.The microporous body may be used as a microporous body manufactured by the following method.
먼저, 상기 미세 다공체를 제조하기 위하여, 미연탄소분, 플라이애쉬, 황토 및 준설토를 준비하고, 상기 미연탄소분, 플라이애쉬, 황토 및 준설토를 일정한 형상으로 성형하기 위한 결합제로 물을 준비할 수 있다. 이때, 상기 황토 및 준설토는 미연탄소분 및 플라이애쉬의 점결성을 향상시키기 위하여 사용될 수 있다.First, in order to manufacture the microporous body, unburned carbon powder, fly ash, red clay, and dredged soil are prepared, and water can be prepared as a binder for molding the unburned carbon powder, fly ash, red clay, and dredged soil into a certain shape. At this time, the red clay and dredged soil can be used to improve the cohesiveness of unburned carbon powder and fly ash.
또한, 상기 미연탄소분, 플라이애쉬, 황토 및 준설토는 각각 미연탄소분 10 내지 15 중량부, 플라이애쉬 8 내지 12 중량부, 황토 2 내지 4 중량부 및 준설토 3 내지 7 중량부의 중량 비율로 혼합되고, 상기 물은 상기 미연탄소분, 플라이애쉬, 황토 및 준설토 전체 100 중량부에 대하여 30 내지 40 중량부의 중량 비율로 혼합될 수 있다.In addition, the unburned carbon powder, fly ash, red clay, and dredged soil are mixed in a weight ratio of 10 to 15 parts by weight of unburned carbon powder, 8 to 12 parts by weight of fly ash, 2 to 4 parts by weight of red clay, and 3 to 7 parts by weight of dredged soil, respectively. Water may be mixed at a weight ratio of 30 to 40 parts by weight based on 100 parts by weight of the total unburned carbon powder, fly ash, red clay, and dredged soil.
다음으로, 상기 미연탄소분, 플라이애쉬, 황토 및 준설토와 물을 혼합하여 혼합물을 제조한 후, 상기 혼합물을 일정한 형상으로 성형하여 성형체를 형성할 수 있다.Next, the unburned carbon powder, fly ash, red clay, dredged soil, and water are mixed to prepare a mixture, and then the mixture can be molded into a certain shape to form a molded body.
즉, 상기 성형체는 미연탄소분 10 내지 15 중량부, 플라이애쉬 8 내지 12 중량부, 황토 2 내지 4 중량부 및 준설토 3 내지 7 중량부의 중량 비율로 혼합하고, 상기 미연탄소분, 플라이애쉬, 황토 및 준설토 전체 100 중량부에 대하여 물 30 내지 40 중량부의 중량 비율로 혼합하여 혼합물을 제조한 후, 상기 혼합물을 구형, 펠릿형 등 다양한 형상으로 성형함으로써 성형체를 제조할 수 있다.That is, the molded body is mixed with 10 to 15 parts by weight of unburned carbon, 8 to 12 parts by weight of fly ash, 2 to 4 parts by weight of red clay, and 3 to 7 parts by weight of dredged soil, and the unburned carbon powder, fly ash, red clay, and dredged soil are mixed in a weight ratio of 10 to 15 parts by weight. A molded body can be manufactured by preparing a mixture by mixing water at a weight ratio of 30 to 40 parts by weight based on a total of 100 parts by weight, and then molding the mixture into various shapes such as spheres and pellets.
그 다음으로, 상기 성형체를 가열하여 소성할 수 있다.Next, the molded body can be heated and fired.
상기 성형체의 소성은 상기 성형체를 가마에서 가열하여 소성할 수 있는데, 상기 가마로는 예를 들어, 터널 가마(tunnel kiln) 또는 불연속 가마가 이용될 수 있고, 상기 가마는 내부 온도를 400 내지 450℃의 온도로 유지하고, 상기 가마의 내부에 상기 성형체를 투입한 후 1200 내지 1300℃의 온도까지 서서히 높이면서 3 내지 5 시간 동안 산화 또는 환원(중성)분위기로 소성할 수 있다.The molded body can be fired by heating the molded body in a kiln. For example, a tunnel kiln or a discontinuous kiln may be used as the kiln, and the kiln has an internal temperature of 400 to 450 ° C. The temperature may be maintained at , and after the molded body is placed inside the kiln, the temperature may be gradually raised to 1200 to 1300° C. and fired in an oxidizing or reducing (neutral) atmosphere for 3 to 5 hours.
이어서, 상기 소성된 성형체를 냉각하여 미세 다공체를 제조할 수 있다.Subsequently, the fired molded body can be cooled to produce a microporous body.
상기 단계에서 상기 소성된 성형체의 냉각은 상기 성형체를 가마로부터 꺼낸 후 200 내지 250℃의 온도에서 1 내지 3시간 동안 냉각한 후, 30 내지 50℃의 온도에서 10 내지 12시간 동안 냉각할 수 있는데, 상기와 같이 2 단계의 냉각 과정을 거쳐 상기 소성된 성형체를 냉각함으로써 급냉에 따른 소성된 성형체의 표면 균열 및 압축 강도의 저하를 방지할 수 있고, 또한, 상기 소성된 성형체 표면에 형성되어 있는 기공의 수축을 방지할 수 있다.Cooling of the fired molded body in the above step may be carried out by cooling the molded body at a temperature of 200 to 250°C for 1 to 3 hours after taking it out of the kiln, and then cooling it at a temperature of 30 to 50°C for 10 to 12 hours. By cooling the fired molded body through a two-step cooling process as described above, it is possible to prevent surface cracks and a decrease in compressive strength of the fired molded body due to rapid cooling, and also to prevent pores formed on the surface of the fired molded body. It can prevent shrinkage.
다음으로, 상기 제3 해수를 냉각하여 결정화한 후 고형분을 제거함으로써 액상 미네랄을 제조할 수 있다.Next, liquid minerals can be produced by cooling the third seawater, crystallizing it, and then removing the solid content.
상기 단계에서는 상기 제3 해수를 냉각장치 내부로 투입한 후, 상기 냉각장치의 온도를 하강시켜 상기 제3 해수의 온도를 낮춤으로써 결정화된 고형물을 형성하고 상기 고형분을 필터 등을 이용하여 제거함으로써 액상미네랄을 제조할 수 있다.In the above step, after the third seawater is introduced into the cooling device, the temperature of the cooling device is lowered to lower the temperature of the third seawater to form crystallized solids and the solids are removed using a filter, etc., thereby forming a liquid phase. Minerals can be manufactured.
즉, 상기 단계에서는 상기 냉각장치의 온도를 하강시킴에 따라 냉각장치에 수용된 제3 해수에 포함되어 있는 염분을 포함하는 고형분이 석출될 수 있는데, 상기 단계에서는 냉각장치의 내부 온도를 1 내지 3℃로 유지하고 20 내지 30시간 동안 냉각하여 결정화한 후 고형분을 제거함으로써 액상미네랄을 제조할 수 있다.That is, in this step, as the temperature of the cooling device is lowered, solids containing salt contained in the third seawater contained in the cooling device may be precipitated. In this step, the internal temperature of the cooling device is set to 1 to 3°C. Liquid minerals can be produced by maintaining and cooling for 20 to 30 hours to crystallize and then removing the solid content.
상기 식물추출물은 오염 물질, 진드기류, 해충 등에 대한 살충, 항균, 항충 효과가 있는 식물들의 유용성분을 추출하여 제조될 수 있는데, 상기 식물추출물은 참바다말(모자반) 추출물, 다시마 추출물, 제충국 추출물, 쿠아시아 추출물, 라이아니아 추출물 및 소태나무 추출물로 이루어지고, 상기 식물추출물은 상기 참바다말(모자반) 추출물 40 내지 50 중량부, 다시마 추출물 10 내지 20 중량부, 제충국 추출물 3 내지 7 중량부, 쿠아시아 추출물 1 내지 5 중량부, 라이아니아 추출물 1 내지 5 중량부 및 소태나무 추출물 3 내지 7 중량부의 중량 비율로 배합되어 혼합될 수 있다.The plant extract can be manufactured by extracting useful components from plants that have insecticidal, antibacterial, and anti-parasitic effects against contaminants, mites, and pests. The plant extract includes seaweed extract, kelp extract, and pyrethrum extract. , It consists of quasia extract, riania extract, and cypress extract, and the plant extract is 40 to 50 parts by weight of the seaweed extract, 10 to 20 parts by weight of kelp extract, and 3 to 7 parts by weight of pyrethrum extract, 1 to 5 parts by weight of Quasia extract, 1 to 5 parts by weight of Rhiania extract, and 3 to 7 parts by weight of Sagittarius extract may be mixed and mixed in a weight ratio of 1 to 5 parts by weight.
상기 참바다말(모자반) 추출물은 참바다말(모자반)로부터 추출될 수 있는데, 상기 참바다말(모자반)은 한국의 전 해안에 널리 분포하고 있는 갈조류로서, 짙은 황갈색을 하고 있으며, 식용으로 이용되는 모자반류의 대표적인 종류이다. 몸은 외견상 뿌리, 줄기 및 잎의 구분이 뚜렷한데, 뿌리는 가반상이며 1개의 중심 가지를 내어 1~3미터 이상 크게 자라며, 줄기는 삼릉주 또는 삼각형이고, 잎은 타원형을 하고 있다.The above-mentioned seaweed (Mojaban) extract can be extracted from the seaweed (Mojaban), which is a brown alga widely distributed along the entire coast of Korea, has a dark yellow-brown color, and is used as food. It is a representative type of moatban. The body has a clear division into roots, stems, and leaves. The roots are spiny and produce one central branch, growing taller than 1 to 3 meters. The stem is triangular or triangular, and the leaves are oval.
상기 참바다말(모자반)은 한국 연안의 해중림을 이루고 있는 대표적인 종류이며, 일본 또는 동남아시아 일대에도 생육하고 있어, 국내 시장에서는 흔히 구할 수 있는 식품에 속한다.The above-mentioned seaweed (Mojaban) is a representative type that forms the marine forest of the Korean coast, and also grows in Japan and Southeast Asia, so it is a commonly available food in the domestic market.
상기 다시마 추출물은 다시마로부터 추출될 수 있는데, 상기 다시마는 한국 및 일본, 사할린섬 등 태평양 연안에 널리 분포하는 다시마속 식물이며, 암갈색을 띠고 뿌리와 줄기, 잎으로 구성된 대형의 다년생 해조류이다. 일반적으로 15에서 35미터 길이와 25에서 40센티미터 정도의 너비를 가지며, 라마닌 성분을 다량 함유하고 있어 혈압을 낮추는데 효과가 높다.The kelp extract can be extracted from kelp, which is a plant of the kelp genus widely distributed along the Pacific coast such as Korea, Japan, and Sakhalin Island, and is a large perennial seaweed that is dark brown and consists of roots, stems, and leaves. It is generally 15 to 35 meters long and 25 to 40 centimeters wide, and contains a large amount of lamanin, which is highly effective in lowering blood pressure.
상기 제충국 추출물은 제충국으로부터 추출될 수 있는데, 상기 제충국(Insect flower, Pyrethrum, Dalmatian pyrethrum)은 쌍떡잎식물 초롱꽃목 국화과의 여러해살이풀로서, 제충국의 꽃에는 피레트린(Pyrethrins)이라는 담적황색의 유상 물질을 함유하고 있다. 피레트린은 냉혈동물, 특히 곤충의 신경계를 마비시켜 강한 살충력을 나타내지만, 사람과 같은 온혈동물에는 독성이 없는 안전한 천연 유래의 살충성분이다. 구체적으로, 피레트린은 곤충에 대한 강한 살충 작용을 지니는바 유제 외에 코일(Coil)형 모기향 등으로서 모기, 파리의 구제에 사용되고 있으며, 바퀴벌레, 벼룩, 개미 및 이와 유사한 기어다니는 곤충에 대해서도 적용 가능한 것으로 알려져 있고, 다른 천연살충제 성분과 혼합되어 작물보호제로 사용되고 있다.The pyrethrum extract can be extracted from pyrethrum, which (Insect flower, Pyrethrum, Dalmatian pyrethrum) is a perennial herb of the dicotyledonous plant Campanula Asteraceae. The flowers of pyrethrum contain a light red-yellow oily substance called pyrethrins. It contains. Pyrethrin exhibits strong insecticidal power by paralyzing the nervous system of cold-blooded animals, especially insects, but is a safe, natural insecticidal ingredient that is not toxic to warm-blooded animals such as humans. Specifically, pyrethrin has a strong insecticidal effect against insects, and is used to exterminate mosquitoes and flies as coil-type mosquito coils in addition to emulsions. It can also be applied to cockroaches, fleas, ants, and similar crawling insects. It is known and mixed with other natural pesticide ingredients to be used as a crop protection agent.
상기 쿠아시아 추출물은 쿠아시아(Quassia amara)로부터 추출될 수 있는데, 상기 쿠아시아(Quassia amara)는 부드럽고 회색의 수피, 복엽, 작고 노란 꽃을 가지고 30cm 정도 자라는 낙엽수이다. 상기 쿠아시아는 나무 전체에 매우 쓴맛을 내는 쿠아신(Quassin)이라고 부르는 레진이 스며들어 있고, 이 성분은 천연 살충제로 사용될 수 있다. 농약으로서 쿠아신은 무당벌레나 벌에 거의 피해를 주지 않으면서 다양한 해충을 구제하기 때문에 가정 원예에서 가장 안전한 재료로 여겨지고 있다.The Quassia extract can be extracted from Quassia amara, a deciduous tree that grows about 30 cm with smooth, gray bark, compound leaves, and small yellow flowers. The entire tree of Quasia is soaked with a resin called Quassin, which has a very bitter taste, and this ingredient can be used as a natural insecticide. As a pesticide, quacin is considered the safest material for home gardening because it exterminates a variety of pests while causing little damage to ladybugs or bees.
상기 라이아니아 추출물은 라이아니아(Ryania speciosa)로부터 추출될 수 있는데, 상기 라이아니아에 함유되어 있는 라이아노딘(ryanodine)은 천연물질로 살충 효과를 나타낼 수 있다. 상기 라이아니아는 버드나무과 사시나무속으로 중남미 열대밀림에서 서식하며, 칼슘이온의 방출을 억제하는 근육 독성 성분이 함유되어 있으며 살충효과는 속효성이지만 식물체내의 이행성은 없다.The Ryania extract can be extracted from Ryania speciosa, and ryanodine contained in Ryania is a natural substance and can have an insecticidal effect. The Liania is a member of the willow and aspen genus and lives in the tropical forests of Central and South America. It contains muscle-toxic ingredients that inhibit the release of calcium ions and has a fast-acting insecticidal effect, but does not migrate within the plant body.
상기 소태나무 추출물은 소태나무(picrasma quassioides)로부터 추출될 수 있는데, 상기 소태나무(picrasma quassioides)는 매우 쓴맛인 콰신(quassin)을 함유하고 있으며 나무껍질에 황색의 피복이 있고 높이는 약 20m 정도까지 자란다. 잎은 우상복엽으로 작은 잎은 광난형이고 밑은 둥글고 끝은 날카롭다. 꽃은 황록색의 자웅 이주로 5~6월경에 취산화서 형태로 액출하고 열매는 핵과로서 타원상 구형이고 9월경에 적색으로 익는다. 잎, 나무껍질, 줄기, 뿌리 등 각 부분을 약재로 사용하는데, 청열조습, 건위, 살충, 해독의 효능이 있어 소화불량, 세균성하리, 위장염, 담도감염, 편도선염에 효과가 있으며, 민간에서 건위제, 소화불량, 위염 및 식욕부진 등 주로 위장을 다스리는 약으로 이용되어 왔다.The extract can be extracted from Picrasma quassioides, which contains quassin, which has a very bitter taste, has a yellow bark, and grows to a height of about 20 m. . The leaves are pinnately compound, and the small leaves are light-ovate, round at the bottom, and sharp at the tip. The flowers are yellow-green, dioecious, and emerge in the form of cymes around May to June. The fruits are drupes, elliptical and spherical, and ripen to red around September. Each part, including leaves, bark, stems, and roots, is used as a medicine. It has the effect of clearing heat and humidity, strengthening the stomach, insecticidal, and detoxifying. It is effective in treating indigestion, bacterial dysentery, gastroenteritis, biliary infection, and tonsillitis. It has been mainly used as a medicine to treat stomach problems such as indigestion, gastritis, and loss of appetite.
또한, 본 발명에서 상기 참바다말(모자반) 추출물, 다시마 추출물, 제충국 추출물, 쿠아시아 추출물, 라이아니아 추출물 및 소태나무 추출물로 이루어진 식물추출물은 공지된 다양한 추출법을 이용하여 제조될 수 있는데, 예를 들어, 상기 식물추출물은 열수 추출법, 유기용매 추출법, 초음파 추출법, 초임계 추출법 등 다양한 추출법을 이용하여 추출될 수 있다.In addition, in the present invention, the plant extract consisting of the seaweed extract, kelp extract, pyrethrum extract, quasia extract, riania extract, and cypress extract can be prepared using various known extraction methods, such as For example, the plant extract can be extracted using various extraction methods such as hot water extraction, organic solvent extraction, ultrasonic extraction, and supercritical extraction.
본 발명에서 상기 참바다말(모자반), 다시마, 제충국, 쿠아시아, 라이아니아 및 소태나무로 이루어진 식물을 추출하여 식물추출물을 제조하는 구성은 당해 기술분야에서는 공지의 기술인바, 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.In the present invention, the composition of producing a plant extract by extracting plants composed of the above-mentioned seaweed, kelp, pyrethrum, quasia, laiania, and cypress is a known technique in the art, and for the convenience of explanation and the present invention. For clarity of the technical idea of the invention, detailed description thereof will be omitted.
상기 오메가-3 지방산(Omega-3 fatty acid)은 신경세포막과 망막에 분포하며, 세포막에서 전기적인 자극을 빠른 속도로 다음 세포에 전달하는 역할을 한다. 체내에서 세포를 보호하고, 세포의 구조를 유지시키며, 원활한 신진대사를 돕는다. 또한, 혈액의 피막형성을 억제하고, 뼈의 형성을 촉진시키는 동시에 강화하는 효과가 있다.The omega-3 fatty acid is distributed in the nerve cell membrane and retina, and plays a role in transmitting electrical impulses from the cell membrane to the next cell at a high speed. It protects cells in the body, maintains cell structure, and helps smooth metabolism. In addition, it has the effect of suppressing blood film formation and promoting and strengthening bone formation.
상기 오메가-3 지방산의 종류에는 알파 리놀렌산(alpha-linolenic acid :LNA), DHA로 알려진 도코사헥사에노산(docosahexaenoic acid), EPA 로 알려진 에이코사펜타에노산(eicosapentaenoic acid), SDA(stearidonic acid), ETA(eicosatetraenoic acid)가 있다.The types of omega-3 fatty acids include alpha-linolenic acid (LNA), docosahexaenoic acid known as DHA, eicosapentaenoic acid known as EPA, and stearidonic acid (SDA). , ETA (eicosatetraenoic acid).
상기 도코사헥사에노익 에시드(Docosahexaenoic acid: DHA)와 에이코사펜타에노익 에시드(Eicosapentaenoic acid: EPA)는 오메가-3 지방산의 일종으로 불포화지방산(polyunsaturated fatty acid: PUFA) 중에서도 가장 필수적인 지방산으로 알려져 있다. 이들 지방산은 자연계에서는 등푸른 생선(mackerel, herring, salmon, tuna), 물개(seal oil) 등 동물들에 다량으로 분포하며 일부 식물에서도 소량으로 존재한다.Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) are types of omega-3 fatty acids and are known to be the most essential fatty acids among polyunsaturated fatty acids (PUFA). . In nature, these fatty acids are distributed in large quantities in animals such as mackerel, herring, salmon, and tuna, and seal oil, and are also present in small amounts in some plants.
상기 초유분말은 초유를 이용하여 제조되는데, 상기 초유는 포유동물이 분만 후 1주일 이내에 분비하는 유즙을 말하며, 최근에는 분만 후 48~72시간 이내에 분비하는 유즙을 초유로 정의하고 있다.The colostrum powder is manufactured using colostrum, which refers to milk secreted by mammals within 1 week after parturition. Recently, colostrum is defined as milk secreted within 48 to 72 hours after parturition.
일반적으로 48시간 이내에 분비되는 초유 속에는 기능성 물질들이 다량 함유되어 있다. 화학적으로 젖소 초유는 매우 복잡한 액상의 물질로서 단백질, 탄수화물, 지방, 비타민, 미네랄 등이 풍부한데, 갓 태어난 송아지에게 영양소를 공급하는 풍부한 에너지원이며 병원성 미생물에 대한 방어, 미성숙한 장관의 발달, 각종 장기와 조직의 성장, 면역체계의 발달 등에 관여하는 면역조절인자, 생리활성인자, 항균인자, 성장호르몬, 성장인자, 세포분열 활성인자 등을 다량 함유하고 있다.Colostrum, which is generally secreted within 48 hours, contains a large amount of functional substances. Chemically, cow colostrum is a very complex liquid substance that is rich in proteins, carbohydrates, fats, vitamins, minerals, etc. It is a rich energy source that supplies nutrients to newborn calves, and is also used to protect against pathogenic microorganisms, develop immature intestinal tract, and support various functions. It contains a large amount of immunoregulatory factors, physiologically active factors, antibacterial factors, growth hormones, growth factors, and cell division activators that are involved in the growth of organs and tissues and the development of the immune system.
이러한 면역적, 생리활성적 특성을 지니고 있는 물질과 인자들은 주로 초유 유장(whey)에 함유되어 있으며, a-lactalbumin, b-lactoglobulin이 70~80%를 차지하고 이외의 단백질 성분들은 serum albumin, lactoferrin, immunoglobulin, growth factor, lysozyme, 미량의 bioactive factor 등이며 각각의 특성을 규명하기 위하여 많은 연구들이 진행되고 있다(Korean J. Food Sci. Technol. Vol.34, No.4, pp.694~699 (2002)).Substances and factors with these immunological and physiologically active properties are mainly contained in colostrum whey, with a-lactalbumin and b-lactoglobulin accounting for 70 to 80%, and other protein components include serum albumin, lactoferrin, immunoglobulin, growth factor, lysozyme, trace amounts of bioactive factors, etc., and many studies are being conducted to identify the characteristics of each (Korean J. Food Sci. Technol. Vol.34, No.4, pp.694~699 (2002 )).
연구에 따르면, 죽상동맥경화증 및 심혈관 질환은 변경된 면역과 관련이 있으며, 심장 및 혈관 조직이 손상되면 항체가 생성되어 면역계가 더욱 손상되며, 여러 연구에서 클라미디아 감염성 폐렴 등은 죽상 경화성 병변의 초기 단계 활성화 및 발달 원인으로 중점을 두고 있다. 소 초유의 면역인자는 이 박테리아와 싸우는데 도움이 되며, 특히 초유에 함유된 프롤린-리치-폴리펩타이드(proline-rich-polypeptide)는 심근합병증으로 진단된 환자에 대해 심근 보호 효과를 갖는 것으로 예상되며, 면역 반응을 조절하여 손상된 혈관의 콜레스테롤 침착을 억제하고, 성장인자는 심장 세포의 복구 및 재생의 촉진, 측부 순환(collateral circulation)을 위한 새로운 관상동맥 혈관 재생을 촉진한다.Studies have shown that atherosclerosis and cardiovascular disease are associated with altered immunity, damage to the heart and vascular tissue leads to the production of antibodies that further damage the immune system, and several studies have shown that chlamydia-infected pneumonia, etc. activates the early stages of atherosclerotic lesions. and development causes. The immune factors in bovine colostrum help fight against these bacteria, and in particular, the proline-rich-polypeptide contained in colostrum is expected to have a myocardial protective effect for patients diagnosed with myocardial complications. By regulating the immune response, it suppresses cholesterol deposition in damaged blood vessels, and growth factors promote the repair and regeneration of heart cells and the regeneration of new coronary vessels for collateral circulation.
또한, 혈압조절 기능과 관련하여, 초유에 존재하는 펩타이드는 레닌-안지오텐신 계에 통합적으로 관여하는 효소인 안지오텐신 I-전환효소(ACE)를 억제하여 혈액의 부피를 낮춤으로서 혈압을 낮추고 심장의 산소소모량을 감소시켜 항 고혈압 및 심혈관질환 개선 효능이 있음을 연구결과로 보고된 바 있다.In addition, with regard to blood pressure regulation function, the peptides present in colostrum inhibit angiotensin I-converting enzyme (ACE), an enzyme integrally involved in the renin-angiotensin system, thereby lowering blood volume, lowering blood pressure and oxygen consumption of the heart. Research results have reported that it has antihypertensive and cardiovascular disease improvement effects by reducing blood pressure.
최근 연구에서 심근경색 쥐(rat) 모델 대상 연구에서 28일간 초유 섭취 후 지질과 산화(항산화)의 억제 및 심장 손상 지표물질(CKMB, LDH)의 감소를 통해 심장 조직 손상 보호 효능이 관찰되었으며, 심부전 치료제(ACE 억제제, 혈압조절제 enalapril)와 복합 섭취 시 그 효능이 더욱 증진됨을 확인되었다(Journal of pharmacology and toxicology 9(1):37-45, 2014).In a recent study on a rat model of myocardial infarction, the efficacy of protecting heart tissue from heart failure was observed through inhibition of lipids and oxidation (antioxidants) and reduction of heart damage indicators (CKMB, LDH) after colostrum intake for 28 days. It was confirmed that the efficacy was further improved when taken in combination with therapeutic agents (ACE inhibitor, blood pressure regulator enalapril) (Journal of pharmacology and toxicology 9(1):37-45, 2014).
또한, 상기 초유에는 Insulin-like Growth Factor-1(IGF-1)이 함유되어 있는데, IGF-1은 전체적인 성장을 촉진하며, 세포 성장과 증폭을 조절할 수 있는 능력을 가지고 있는 것으로 알려져 있다In addition, the colostrum contains Insulin-like Growth Factor-1 (IGF-1), which is known to promote overall growth and has the ability to regulate cell growth and amplification.
본 발명에서 상기 초유분말은 하기의 방법으로 제조된 초유분말이 사용될 수도 있다.In the present invention, the colostrum powder may be used as the colostrum powder prepared by the following method.
상기 초유분말을 제조하기 위하여, 먼저, 소 초유를 준비하고 상기 준비된 소 초유에 효소를 혼합한 후 보관하여 효소 분해할 수 있다.To prepare the colostrum powder, first, prepare bovine colostrum, mix enzymes with the prepared bovine colostrum, and then store it for enzymatic decomposition.
즉, 상기 단계에서는 상기 준비된 소 초유에 효소를 혼합한 후 상기 효소가 혼합된 소 초유를 36 내지 38℃의 온도에서 20 내지 30시간 동안 보관함으로써 효소 분해할 수 있다.That is, in the above step, enzymes can be mixed into the prepared bovine colostrum, and then the bovine colostrum mixed with the enzymes is stored at a temperature of 36 to 38° C. for 20 to 30 hours to enzymatically decompose.
상기 단계에서 상기 효소로는 시중에 판매되고 있는 공지된 프로테아제(Protease) 및 자일라나제(Xylanase)가 이용될 수 있는데, 예를 들어, 상기 프로테아제(Protease)로는 키모트립신(chymotrypsin)이 사용될 수 있고, 상기 키모트립신은 단백질 분해를 일으키는 소화 효소이다.In this step, known commercially available proteases and xylanases may be used as the enzymes. For example, chymotrypsin may be used as the protease. , the chymotrypsin is a digestive enzyme that causes protein breakdown.
즉, 상기 키모트립신은 단백질 분해를 일으키는 소화 효소로 펩티드 결합을 끊는데, 상기 키모트립신은 포유동물과 다른 생물체의 소화계에서 단백질 분해효소로 작용한다. 상기 키모트립신의 기질로는 트립토판, 티로신, 페닐알라닌, 류신, 메티오닌이 있으며 이들의 카복시 말단을 잘라낸다. 다른 단백질 분해효소와 같이 펩티드 결합을 끊는 반응을 일으킨다.In other words, chymotrypsin is a digestive enzyme that causes protein decomposition and breaks peptide bonds, and chymotrypsin acts as a proteolytic enzyme in the digestive system of mammals and other living organisms. The substrates of chymotrypsin include tryptophan, tyrosine, phenylalanine, leucine, and methionine, and their carboxy termini are cut off. Like other proteolytic enzymes, it causes a reaction that breaks peptide bonds.
또한, 상기 자일라나제(Xylanase)는 자일란(xylan)을 자일로올리고당(xylo-oligosaccharide)나 자일로스(Xylose)로 가수분해하는 효소로서 바이오에너지, 식품, 섬유, 제지 및 펄프 산업에 사용되고 있는 효소이다. 지구상에서 가장 풍부한 생물자원인 식물성 섬유소를 분해하고 당화하여 바이오에탄올 생산하는 분야에서 연구가 활발히 진행되고 있으며 고급 용지의 생산 및 폐지재생, 과일음료 및 맥주의 혼탁물 제거, 커피와 식물성 기름 및 전분의 추출 그리고 단위동물의 사료이용 효율 증대와 같은 용도로 이미 산업적으로 널리 사용되고 있는 효소이다.In addition, the xylanase is an enzyme that hydrolyzes xylan into xylo-oligosaccharide or xylose and is used in the bioenergy, food, fiber, paper and pulp industries. am. Research is actively underway in the field of producing bioethanol by decomposing and saccharifying vegetable fiber, the most abundant biological resource on earth, including production of high-quality paper and recycling of waste paper, removal of turbidity from fruit drinks and beer, and production of coffee, vegetable oil and starch. It is an enzyme that is already widely used industrially for purposes such as extraction and increasing the efficiency of feed use by monogastric animals.
구체적으로는 상기 단계에서 상기 효소는 상기 준비된 소 초유 전체 100 중량부에 대해, 상기 키모트립신과 같은 프로테아제(Protease) 0.01 내지 0.03 중량부 및 자일라나제(Xylanase) 0.008 내지 0.012 중량부의 중량 비율로 혼합될 수 있다.Specifically, in the above step, the enzyme is mixed at a weight ratio of 0.01 to 0.03 parts by weight of protease such as chymotrypsin and 0.008 to 0.012 parts by weight of xylanase, based on 100 parts by weight of the total bovine colostrum prepared. It can be.
다음으로, 상기 효소 분해된 소 초유에 배양액 및 유산균으로 이루어진 발효액을 혼합할 수 있다.Next, the enzyme-digested bovine colostrum can be mixed with a fermentation broth consisting of a culture broth and lactic acid bacteria.
상기 단계에서 상기 유산균으로는 젖산균(Lactobacillales), 스트렙토코쿠스 테르모필루스(Streptococcus thermophiles) 및 비피도박테리움 롱굼(Bifidobacterium longum)으로 이루어진 군에서 선택된 어느 하나의 공지된 유산균이 이용될 수 있고, 상기 배양액은 펩톤, 맥아추출물(Malt extract), 시트르산나트륨(Sodium citrate), 제2인산칼륨(Potassium phosphate dibasic), 글루코스(Glucose) 및 증류수로 이루어지고, 상기 배양액은 펩톤 15 내지 25 중량부, 맥아추출물 5 내지 15 중량부, 시트르산나트륨 0.5 내지 1.5 중량부, 제2인산칼륨 0.1 내지 0.3 중량부, 글루코스 1 내지 3 중량부 및 증류수 100 내지 200 중량부의 중량 비율로 혼합되어 이루어질 수 있다.In the above step, any known lactic acid bacteria selected from the group consisting of lactic acid bacteria ( Lactobacillales ), Streptococcus thermophiles and Bifidobacterium longum can be used, The culture medium consists of peptone, malt extract, sodium citrate, potassium phosphate dibasic, glucose, and distilled water, and the culture medium contains 15 to 25 parts by weight of peptone and malt extract. It may be mixed in a weight ratio of 5 to 15 parts by weight, 0.5 to 1.5 parts by weight of sodium citrate, 0.1 to 0.3 parts by weight of potassium dibasic phosphate, 1 to 3 parts by weight of glucose, and 100 to 200 parts by weight of distilled water.
상기 배양액에서 상기 펩톤은 단백질을 공급해주는 질소원으로서 미생물의 성장에 필요한 단백질을 공급해 주며, 상기 맥아추출물은 각종 미네랄, 비타민 B군, 아미노산이 포함되어 있어 미생물 성장에 도움을 줄 수 있으며, 상기 시트르산나트륨은 배양액의 pH를 조절하여 미생물의 성장에 최적화된 상태를 유지해 주는 무기질로, 영양을 공급해 줄 수 있고, 상기 글루코스는 유산균이 당을 대사하여 유기산을 만들어내는 중요한 성분으로 기능할 수 있다.In the culture medium, the peptone is a nitrogen source that supplies protein, which is necessary for the growth of microorganisms. The malt extract contains various minerals, B vitamins, and amino acids, which can help the growth of microorganisms, and the sodium citrate Silver is a mineral that maintains an optimal state for the growth of microorganisms by adjusting the pH of the culture medium and can provide nutrients, and the glucose can function as an important ingredient in which lactic acid bacteria metabolize sugar to produce organic acids.
그 다음으로, 상기 발효액이 혼합된 소 초유를 발효시켜 소 초유 발효물을 제조할 수 있다.Next, fermented bovine colostrum can be produced by fermenting bovine colostrum mixed with the fermentation broth.
상기 단계에서 상기 발효는 상기 발효액이 혼합된 소 초유를 38 내지 42℃의 온도에서 1 내지 3일 동안 보관하여 발효시킬 수 있다.In the above step, the fermentation can be carried out by storing the bovine colostrum mixed with the fermentation broth at a temperature of 38 to 42 ° C. for 1 to 3 days.
이어서, 상기 소 초유 발효물을 여과하여 불순물을 제거하고 동결 건조한 후 분쇄하여 초유분말을 제조할 수 있다.Next, the fermented bovine colostrum can be filtered to remove impurities, freeze-dried, and pulverized to prepare colostrum powder.
상기 단계에서는 공지의 여과기를 이용하여 소 초유 발효물을 여과함으로써 상기 소 초유 발효물에 잔류하는 불순물을 제거할 수 있고, 상기 여과된 소 초유 발효물을 -40℃ 내지 -30℃ 온도의 범위에서 1 내지 3시간 동안 동결 건조한 후 분쇄하여 초유분말을 제조할 수 있다.In this step, impurities remaining in the fermented bovine colostrum can be removed by filtering the fermented bovine colostrum using a known filter, and the filtered fermented bovine colostrum is stored at a temperature in the range of -40°C to -30°C. Colostrum powder can be prepared by freeze-drying for 1 to 3 hours and then grinding.
본 발명에서는 상기와 같이 소 초유를 효소 분해하고 유산균 발효를 진행하여 초유분말을 제조함으로써, 초유 대표 생리활성 물질인 프롤린-리치-폴리펩타이드(proline-rich-polypeptide; PRP) 등의 면역기능 성분의 유효량을 높일 수 있다.In the present invention, bovine colostrum is enzymatically decomposed and lactic acid bacteria fermented as described above to produce colostrum powder, thereby containing immune function components such as proline-rich-polypeptide (PRP), a representative bioactive substance of colostrum. The effective dose can be increased.
상기 타피오카 전분은 가축용 배합사료에 포함되어 탄수화물 공급원 및 점도를 형성하는 역할을 하는데, 상기 타피오카 전분은 열대작물인 카사바의 뿌리에서 채취한 식용 녹말로, 카사바의 뿌리는 생것의 경우 20~30%의 녹말을 함유하고 있고, 이것을 짓이겨 녹말을 물로 씻어내 침전시킨 후 건조시켜서 타피오카를 만든다.The tapioca starch is included in the mixed feed for livestock and serves as a source of carbohydrates and forms viscosity. The tapioca starch is an edible starch collected from the roots of cassava, a tropical crop. The roots of cassava are 20 to 30% raw. It contains starch, and tapioca is made by crushing it, washing the starch with water, letting it precipitate, and then drying it.
상기 타피오카의 효능은 100 칼로리당 26 그램의 탄수화물로 설탕, 지방 및 단백질 칼로리는 제로에 가깝다. 또한 타피오카는 무가당에 글루텐이 없고, 카사바로 만든 제품은 소화하기 쉽고 IBS 또는 IBD와 같은 소화 문제가 있는 사람들에게 종종 권장되며 민감한 소화 시스템을 가진 사람들이나 밀가루를 먹는데 어려움을 겪고 있는 사람들이 섭취할 수 있다.The benefits of tapioca include 26 grams of carbohydrates per 100 calories, and close to zero calories from sugar, fat, and protein. Additionally, tapioca is unsweetened and gluten-free, and products made from cassava are easy to digest and are often recommended for people with digestive issues such as IBS or IBD and can be consumed by people with sensitive digestive systems or those who have difficulty eating wheat flour. there is.
상기 미강은 현미를 도정하여 정백미를 만들 때에 얻어지는 외피와 배아의 분쇄혼합물을 의미하며, 쌀겨라고도 한다. 상기 미강은 단백질, 식이섬유, 필수 지방산, 필수 아미노산, 비타민 B, E 및 미네랄을 함유하며, 섬유질이 풍부하여 숙변 제거 및 대장의 연동운동 활성화 효과를 가진다.The rice bran refers to a pulverized mixture of the outer skin and embryo obtained when polishing brown rice to make polished rice, and is also called rice bran. The rice bran contains protein, dietary fiber, essential fatty acids, essential amino acids, vitamins B, E and minerals, and is rich in fiber, which has the effect of removing stool and activating peristalsis in the large intestine.
상기 대두분말은 대두(大豆)를 분말화하여 제조될 수 있는데, 상기 대두(大豆)는 쌀에 부족한 단백질과 지질을 보완 공급하는 역할을 담당하고 있으며, 단백질 35~40%, 유지 15~20%를 함유하고 있는데, 이 중 80% 이상 불포화지방산으로 콜레스테롤 저하 및 각종 심혈관계 질환 예방에 효과적이다. 콩의 기능성 성분은 여성 호르몬인 에스트로겐(estrogen)과 구조적으로 유사하며, 고혈압, 동맥경화 등 순환기 질환과 골다공증에 효과가 있는 이소플라본이 있다. 또한, 사포닌은 항암 및 노화 방지에 효과적이고, phytic acid는 인체에 해로운 중금속 이온들과 용이하게 결합하여 체외로 쉽게 배설하는 기능이 있으며 이외에도 trypsin inhibitor, hemaglutinin, 올리고당 등이 콩에 함유된 생리활성 물질로 알려져 있다.The soybean powder can be manufactured by pulverizing soybeans. The soybeans play a role in supplementing the protein and lipids that rice lacks, and contain 35-40% protein and 15-20% oil. It contains more than 80% of these unsaturated fatty acids, which are effective in lowering cholesterol and preventing various cardiovascular diseases. The functional ingredients of soybeans are structurally similar to the female hormone estrogen, and include isoflavones, which are effective in treating circulatory diseases such as high blood pressure and arteriosclerosis and osteoporosis. In addition, saponin is effective in anti-cancer and anti-aging, and phytic acid has the function of easily binding to heavy metal ions harmful to the human body and easily excreting them out of the body. In addition, trypsin inhibitor, hemaglutinin, and oligosaccharide are bioactive substances contained in soybeans. It is known as
또한, 대두의 가장 대표적인 기능성 성분인 이소플라본(isoflavone)류(genistein, daidzein, glycitein)는 항산화 효과가 있고, 에스트로겐(estrogen) 수용체를 blocking 함으로써 유방암과 난소암을 억제하는 효과가 있는 것으로 알려져 있다.In addition, isoflavones (genistein, daidzein, glycitein), the most representative functional ingredients of soybeans, are known to have an antioxidant effect and are effective in suppressing breast and ovarian cancer by blocking estrogen receptors.
상기 이소플라본(isoflavone)류 이외의 기능성 성분으로서 콩 펩타이드는 콜레스테롤의 저하, 혈압강하, 면역부활, 혈소판 응집저해 등의 활성을 가지고 Inositol과 phytate의 경우 항암효과가 있는 것으로 알려져 있으며, 대두 사포닌은 비만억제, 혈중콜레스테롤의 감소, 항암, HIV증식억제, 노화방지 등의 작용을 가지며 그 외에도 콩 성분은 피부암, 방광암, 폐암, 결장암, 췌장암, 식도암, 전립선암, 간암, 위암 등에도 유효함이 연구를 통해 밝혀졌다.As functional ingredients other than the isoflavones, soy peptides have activities such as lowering cholesterol, lowering blood pressure, reviving immunity, and inhibiting platelet aggregation. Inositol and phytate are known to have anticancer effects, and soy saponins are known to have anti-cancer effects. It has effects such as inhibition, reduction of blood cholesterol, anti-cancer, inhibition of HIV proliferation, and anti-aging. In addition, studies have shown that soybean ingredients are effective in skin cancer, bladder cancer, lung cancer, colon cancer, pancreas cancer, esophageal cancer, prostate cancer, liver cancer, and stomach cancer. It was revealed through
이하, 본 발명에 따른 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료에 대한 실시예 및 비교예를 들어 더욱 구체적으로 설명하기로 한다.Hereinafter, the mixed feed for livestock containing black soldier flies, almond blood, and egg shells according to the present invention will be described in more detail through examples and comparative examples.
< 실시예 1 ><Example 1>
동애등에 50 중량부, 아몬드피 15 중량부, 난각 15 중량부, 메틸설포닐메탄 10 중량부, 초록입홍합 10 중량부, 해조칼슘 2 중량부, 홍화씨 2 중량부, 키토산올리고당 1.5 중량부, 스피룰리나(spirulina) 5 중량부, 액상미네랄 2 중량부, 식물추출물 2 중량부, 오메가-3 지방산 3 중량부, 초유분말 1 중량부, 타피오카 전분 10 중량부, 미강 15 중량부 및 대두분말 3 중량부의 중량 비율로 혼합한 후 압축 성형하여 가축용 배합사료를 제조하였다.50 parts by weight of black soldier fly, 15 parts by weight of almond blood, 15 parts by weight of egg shell, 10 parts by weight of methylsulfonylmethane, 10 parts by weight of green lipped mussel, 2 parts by weight of seaweed calcium, 2 parts by weight of safflower seeds, 1.5 parts by weight of chitosan oligosaccharide, spirulina (Spirulina) 5 parts by weight, liquid mineral 2 parts by weight, plant extract 2 parts by weight, omega-3 fatty acid 3 parts by weight, colostrum powder 1 part by weight, tapioca starch 10 parts by weight, rice bran 15 parts by weight and soybean powder 3 parts by weight Mixed feed for livestock was prepared by mixing in proportions and compression molding.
< 실시예 2 ><Example 2>
동애등에 55 중량부, 아몬드피 12 중량부, 난각 19 중량부, 메틸설포닐메탄 6 중량부, 초록입홍합 14 중량부, 해조칼슘 2 중량부, 홍화씨 2 중량부, 키토산올리고당 1.5 중량부, 스피룰리나(spirulina) 6 중량부, 액상미네랄 1.5 중량부, 식물추출물 2.5 중량부, 오메가-3 지방산 2 중량부, 초유분말 1.4 중량부, 타피오카 전분 14 중량부, 미강 11 중량부 및 대두분말 3 중량부의 중량 비율로 혼합한 후 압축 성형하여 가축용 배합사료를 제조하였다.55 parts by weight of black soldier fly, 12 parts by weight of almond blood, 19 parts by weight of eggshell, 6 parts by weight of methylsulfonylmethane, 14 parts by weight of green lipped mussel, 2 parts by weight of seaweed calcium, 2 parts by weight of safflower seeds, 1.5 parts by weight of chitosan oligosaccharide, spirulina (Spirulina) 6 parts by weight, liquid mineral 1.5 parts by weight, plant extract 2.5 parts by weight, omega-3 fatty acid 2 parts by weight, colostrum powder 1.4 parts by weight, tapioca starch 14 parts by weight, rice bran 11 parts by weight and soybean powder 3 parts by weight Mixed feed for livestock was prepared by mixing in proportions and compression molding.
< 비교예 1 ><Comparative Example 1>
실시예 1과 동일한 조성물을 이용하여 가축용 배합사료를 제조하였는데, 비교예 1에서는 등애등에, 아몬드피, 초록입홍합 및 스피룰리나를 포함하지 않고 가축용 배합사료를 제조하였다.A mixed feed for livestock was prepared using the same composition as in Example 1. In Comparative Example 1, a mixed feed for livestock was prepared without including yellowtail, almond blood, green-lipped mussel, and spirulina.
< 비교예 2 ><Comparative Example 2>
실시예 1과 동일한 조성물을 이용하여 가축용 배합사료를 제조하였는데, 비교예 2에서는 등애등에, 난각, 액상미네랄 및 초유분말을 포함하지 않고 가축용 배합사료를 제조하였다.A mixed feed for livestock was prepared using the same composition as in Example 1, but in Comparative Example 2, a mixed feed for livestock was prepared without including bluegills, egg shells, liquid minerals, and colostrum powder.
1. 기호성 조사1. Palatability investigation
체중 180~230㎏이고 월령이 6~9개월인 한우 15마리를 대상으로 5일 동안 실시예 1, 2와 비교예 1, 2의 가축용 배합사료를 각각 동일량씩 동시에 급여하여 사료 소진률을 비교하여 기호성을 조사하였다.Feed consumption rates were compared by simultaneously feeding equal amounts of the mixed livestock feeds of Examples 1 and 2 and Comparative Examples 1 and 2 to 15 Korean cattle weighing 180 to 230 kg and aged 6 to 9 months for 5 days. The palatability was investigated.
상기 [표 1]을 참조하면, 실시예 1, 실시예 2에 따른 가축용 배합사료의 소진율이 높게 나타났는데, 이를 통해 한우가 실시예 1, 실시예 2에 따른 가축용 배합사료의 섭취를 더 선호한다는 것을 확인할 수 있었다.Referring to [Table 1] above, the consumption rate of the mixed feed for livestock according to Examples 1 and 2 was found to be high, which showed that Korean beef was consuming more of the mixed feed for livestock according to Examples 1 and 2. I was able to confirm that I preferred it.
2. 체중 변화2. Weight change
체중 180~230㎏이고 월령이 6~9개월인 한우 15마리를 대상으로 5일 동안 실시예 1, 2와 비교예 1, 2의 가축용 배합사료를 각각 동일량씩 동시에 급여하고, 실험 초기 및 마감시의 체중을 측정하여 평균값을 비교하였다.Fifteen Korean cattle weighing 180 to 230 kg and aged 6 to 9 months were fed equal amounts of the livestock feeds of Examples 1 and 2 and Comparative Examples 1 and 2 at the same time for 5 days, at the beginning and end of the experiment. The body weight was measured and the average values were compared.
상기 [표 2]를 참조하면, 실시예 1, 실시예 2에 따른 가축용 배합사료를 섭취한 한우의 체중 변화가 높게 나타났는데, 이를 통해 한우가 실시예 1, 실시예 2에 따른 가축용 배합사료가 영양 성분이 더 풍부하여 한우가 사료의 섭취를 더 선호한다는 것을 확인할 수 있었다.Referring to [Table 2], the change in body weight of Korean beef that consumed the mixed feed for livestock according to Examples 1 and 2 was found to be high, which showed that Korean beef was fed with the mixed feed for livestock according to Examples 1 and 2. It was confirmed that Korean beef preferred to consume the feed because the feed was richer in nutrients.
이상, 본 발명의 바람직한 일 실시예를 설명하였지만, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 일 실시예는 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.Although a preferred embodiment of the present invention has been described above, those skilled in the art will understand that the present invention can be implemented in other specific forms without changing the technical idea or essential features. You will be able to. Therefore, the embodiment described above should be understood as illustrative in all respects and not restrictive.
Claims (3)
상기 동애등에, 아몬드피 및 난각 이외에, 메틸설포닐메탄, 초록입홍합, 해조칼슘, 홍화씨, 키토산올리고당, 스피룰리나(spirulina), 액상미네랄, 식물추출물, 오메가-3 지방산, 초유분말, 타피오카 전분, 미강 및 대두분말을 포함하고,
상기 동애등에 40 내지 60 중량부, 아몬드피 10 내지 20 중량부, 난각 10 내지 20 중량부, 메틸설포닐메탄 5 내지 15 중량부, 초록입홍합 5 내지 15 중량부, 해조칼슘 1 내지 3 중량부, 홍화씨 1 내지 3 중량부, 키토산올리고당 0.5 내지 2.5 중량부, 스피룰리나(spirulina) 3 내지 7 중량부, 액상미네랄 1 내지 3 중량부, 식물추출물 1 내지 3 중량부, 오메가-3 지방산 2 내지 4 중량부, 초유분말 0.5 내지 1.5 중량부, 타피오카 전분 5 내지 15 중량부, 미강 10 내지 20 중량부 및 대두분말 1 내지 5 중량부의 중량 비율로 포함된 것을 특징으로 하는 동애등에, 아몬드피, 난각을 포함하는 가축용 배합사료.Contains black soldier fly, almond skin, and eggshell as main ingredients,
In addition to the above black soldier flies, almond blood and eggshells, methylsulfonylmethane, green-lipped mussels, seaweed calcium, safflower seeds, chitosan oligosaccharides, spirulina, liquid minerals, plant extracts, omega-3 fatty acids, colostrum powder, tapioca starch, and rice bran. and soybean powder,
40 to 60 parts by weight of Dongae, 10 to 20 parts by weight of almond blood, 10 to 20 parts by weight of eggshell, 5 to 15 parts by weight of methylsulfonylmethane, 5 to 15 parts by weight of green lipped mussel, 1 to 3 parts by weight of seaweed calcium. , 1 to 3 parts by weight of safflower seeds, 0.5 to 2.5 parts by weight of chitosan oligosaccharides, 3 to 7 parts by weight of spirulina, 1 to 3 parts by weight of liquid minerals, 1 to 3 parts by weight of plant extract, 2 to 4 parts by weight of omega-3 fatty acids. 0.5 to 1.5 parts by weight of colostrum powder, 5 to 15 parts by weight of tapioca starch, 10 to 20 parts by weight of rice bran, and 1 to 5 parts by weight of soybean powder, including black soldier flies, almond skin, and eggshell. Combined feed for livestock.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210069158A KR102609440B1 (en) | 2021-05-28 | 2021-05-28 | Mixed feed for livestock including black soldier fly, almond shell and egg shell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210069158A KR102609440B1 (en) | 2021-05-28 | 2021-05-28 | Mixed feed for livestock including black soldier fly, almond shell and egg shell |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220161625A KR20220161625A (en) | 2022-12-07 |
KR102609440B1 true KR102609440B1 (en) | 2023-12-05 |
Family
ID=84441049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210069158A KR102609440B1 (en) | 2021-05-28 | 2021-05-28 | Mixed feed for livestock including black soldier fly, almond shell and egg shell |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102609440B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003061588A (en) * | 2001-04-17 | 2003-03-04 | Morinda Inc | Morinda citrifolia (noni) enhanced animal food product |
US20030194423A1 (en) * | 2002-04-15 | 2003-10-16 | Mars, Inc. | Composition for enhancing nutritional content of food |
JP2004357506A (en) | 2003-05-30 | 2004-12-24 | Fancl Corp | Supplement for pet |
CN108719645A (en) * | 2018-06-12 | 2018-11-02 | 宁波科瑞特动物药业有限公司 | A kind of effective novel creep feed companion |
CN111165676A (en) | 2020-01-13 | 2020-05-19 | 青岛博隆实验动物有限公司 | Additive for colostrum substitute of puppy, preparation method and application |
KR102183599B1 (en) * | 2019-07-17 | 2020-11-26 | (주)마이티워터 | Feed additives for the sterilization, deodorization and promotion of decomposting of decomposted organic fertilizers and method of manufacture the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100889397B1 (en) | 2007-03-28 | 2009-03-19 | 주식회사 이지바이오시스템 | Environmental friendly Feed Composite for A Pig |
KR101110583B1 (en) * | 2009-09-14 | 2012-02-15 | 김창경 | Method of preparing chito-oilgosaccharide containing enhanced calcium and chito-oilgosaccharide containing enhanced calcium obtained Therefrom |
KR101756039B1 (en) | 2016-11-21 | 2017-07-10 | 이성수 | Manufacturing method of composition of feed for ruminant |
KR102009193B1 (en) | 2017-06-07 | 2019-08-12 | 김학규 | A composition of Supplemental feed for ruminant including salicomia herbacea and manufacturing method thereof |
-
2021
- 2021-05-28 KR KR1020210069158A patent/KR102609440B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003061588A (en) * | 2001-04-17 | 2003-03-04 | Morinda Inc | Morinda citrifolia (noni) enhanced animal food product |
US20030194423A1 (en) * | 2002-04-15 | 2003-10-16 | Mars, Inc. | Composition for enhancing nutritional content of food |
JP2004357506A (en) | 2003-05-30 | 2004-12-24 | Fancl Corp | Supplement for pet |
CN108719645A (en) * | 2018-06-12 | 2018-11-02 | 宁波科瑞特动物药业有限公司 | A kind of effective novel creep feed companion |
KR102183599B1 (en) * | 2019-07-17 | 2020-11-26 | (주)마이티워터 | Feed additives for the sterilization, deodorization and promotion of decomposting of decomposted organic fertilizers and method of manufacture the same |
CN111165676A (en) | 2020-01-13 | 2020-05-19 | 青岛博隆实验动物有限公司 | Additive for colostrum substitute of puppy, preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
KR20220161625A (en) | 2022-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102287247B1 (en) | The composition of joint nutritional supplement for companion animals | |
Hossain et al. | Chemical composition of date-pits and its potential for developing value-added product-a review | |
KR101949105B1 (en) | Chicken feed composition and preparing method thereof | |
KR101519506B1 (en) | Additive composition for shrimp feed and a method for producing the same | |
KR102451530B1 (en) | Method for manufacturing soil conditioner and organic carbon fertilizer using biochar | |
CN101965927B (en) | Hatch feed for zebra fish fry | |
KR102650031B1 (en) | Composition for improving companion animal heart function and functional food containing the same | |
KR102339573B1 (en) | Functional Feed Additive Composition For pets | |
KR102384011B1 (en) | Manufacturing method of functional animal feeds using multi functional coating composition for removing excretions odor and enriching nutrition and functional animal feeds manufactured by the same | |
KR101956516B1 (en) | Chicken feed composition and preparing method thereof | |
KR100913611B1 (en) | Additive for fishes feed using photosynthetic bacteria and feed comprising it | |
KR102620485B1 (en) | Manufacturing method of drinking water for animal growth promotion containing mineral water and acanthopanax sessiliflorum extract, and drinking water produced thereby | |
CN106720956A (en) | A kind of carp feed | |
KR101035727B1 (en) | Functional feed additives using skin of fish and manufacturing method thereof, functional feed for fish farming | |
KR102183599B1 (en) | Feed additives for the sterilization, deodorization and promotion of decomposting of decomposted organic fertilizers and method of manufacture the same | |
KR102365888B1 (en) | Drinking water manufacturing method and poultry breeding method using the same | |
KR102609440B1 (en) | Mixed feed for livestock including black soldier fly, almond shell and egg shell | |
KR101913806B1 (en) | Nutrient for animal and plant life using marine aquatic products and method of manufacturing thereof | |
KR102333548B1 (en) | Animal feed composition comprising bass extract and preparation method thereof | |
KR102161025B1 (en) | Shrimp feed composition comprising Leaves and Steams of Cudrania tricuspidata ferment liquids and powder | |
KR101938942B1 (en) | Livestock feed for Sea Cucumber and the feed of manufacturing | |
KR102617364B1 (en) | Aquaphonics-based agricultural and marine product complex cultivation system | |
KR102119199B1 (en) | Perilla leaf feed and manufacturing method thereof | |
KR102609443B1 (en) | Feed for companion animals including black soldier fly, juice pieces and egg shell | |
KR100454228B1 (en) | A feed additive for cultured fish |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |